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The B cell receptor (BCR) serves as both signal-transducer and antigen-transporter.  
Binding of antigens to the BCR induces signaling cascades and antigen-processing and 
presentation, two essential cellular events for B cell activation.  BCR-initiated signaling 
increases BCR-mediated antigen-processing efficiency by increasing the rate and 
specificity of antigen transport.  Previous studies showed a critical role for the actin 
cytoskeleton in these two processes.  Here I found that actin-binding protein 1 
(Abp1/HIP-55/SH3P7) functioned as an actin-binding adaptor protein, coupling BCR 
signaling and antigen-processing pathways with the actin cytoskeleton.   Gene knockout 
of Abp1 and over-expression of the SH3 domain of Abp1 inhibited BCR-mediated 
antigen internalization, consequently reducing the rate of antigen transport to processing 
compartments and the efficiency of BCR-mediated antigen-processing and presentation.  
BCR activation induced tyrosine phosphorylation of Abp1 and translocation of both 
Abp1 and dynamin 2 from the cytoplasm to the plasma membrane, where they 
colocalized with the BCR and cortical F-actin. The inhibitory effect of a dynamin PRD 
deletion mutant on the recruitment of Abp1 to the plasma membrane and the 
internalization of the BCR, co-immunoprecipitation of dynamin with Abp1, and co-
precipitation of Abp1 with GST fusion of the dynamin PRD, demonstrate the interaction 
of Abp1 with dynamin 2. In addition to its role in antigen transport and processing, Abp1 
is also important for BCR signal transduction. Splenic B cells from Abp1 knockout mice 
and A20 B cell line with Abp1 knockdown displayed higher levels of protein tyrosine 
phosphorylation after BCR crosslinking when compared with wild type mice.  BCR-
triggered ERK phosphorylation in Abp1-deficient splenic B cells occurred sooner and for 
a much shorter duration than the wild type B cells, while both Abp1 knockout and 
knockdown significantly reduced BCR-induced phosphorylation of JNK. These results 
demonstrate that the BCR regulates the function of Abp1 by inducing Abp1 
phosphorylation and actin cytoskeleton rearrangement, and that Abp1 facilitates BCR-
mediated antigen-processing by simultaneously interacting with dynamin and the actin 
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Chapter 1: Introduction 
1.1 Humoral immunity 
Our body defends us against microorganisms using two major types of immunity, an 
early, innate immunity that recognizes a limited set of molecular patterns on the surfaces 
of microbes and a later, more specific adaptive immunity (1). The adaptive immunity can 
be further subdivided into two main types, humoral immunity and cell-mediated 
immunity. Cell-mediated or cellular immunity is mediated by T cells, while humoral 
immunity is mediated by B cells. The B cell produces a protein complex called antibodies 
(immunoglobulin) in secreted and membrane-bound forms.  Antibodies are the primary 
effectors of humoral immunity.  An antibody is a complex made up of two identical light 
chains and two identical heavy chains. At the N-terminal region of both the heavy and 
light chain of antibodies the amino acid sequences of antibodies have a high degree of 
variation.  This region, termed the variable region, is responsible for conferring on the 
antibody its ability to bind to billions of molecules that the body might encounter during 
the course of its lifetime (2-5). Secreted antibodies reside in most of the body fluids and 
they can bind to microorganisms and foreign antigens, neutralizing their toxicity, 
targeting them for destruction by other arms of the immune system. Antibodies also exist 
in a membrane-bound form on the surface of the B cell. Here, they are termed B cell 
antigen receptors (BCR). The BCR also has the capability to recognize and bind to 
foreign antigens. Binding of antigens to the BCR leads to a series of signaling cascades 
that activate the B cells. These signals also facilitate the rapid internalization of the 
antigen to compartments within the B cell for processing into peptides and later presented 
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to T cells on structures called major histocompatibility complex class II (MIIC) 
Presentation to T cells enables the B cell to receive additional signals that allow the B cell 
to participate more effectively in adapting the immune response to the offending antigen.  
 
1.2 BCR Signaling 
The BCR is a multi-subunit protein complex composed of a membrane immunoglobulin 
(mIg), which associates non-covalently with the Igα/Igβ heterodimer (Fig. 1.1).  The 
membrane-bound Ig on the cell surface is responsible for antigen binding, while the 
Igα/Igβ propagates intracellular signals (6).  The mIg portion of the BCR is made up of 
two light chains and two heavy chains, thus creating two antigen binding sites. The Igα 
and Igβ each contain one immunoreceptor tyrosine-based activation motif (ITAM) in 
their cytoplasmic tails, providing the BCR with signal transduction capabilities (7).  Each 
ITAM has two copies of the amino acid sequence YXXφ (D/E XX-YXXφ-X6-8-YXXφ), 
where Y is a tyrosine, X is any amino acid, and φ is a bulky hydrophobic amino acid (8). 
The recognition of antigens with repeated epitopes by multiple, individual molecules of 
BCR, causes these receptors to aggregate, leading to the activation of signaling cascades 
that are mediated by the Igα/Igβ complex. BCR crosslinking by antigen leads to a rapid 
translocation of the BCR to cholesterol-rich lipid rafts where it interacts with signaling 
proteins (9). In lipid rafts, the ITAMs of the BCR are phosphorylated by the Src-family 
kinases, Lyn, Fyn or Blk, which are either constitutively associated or become associated 
with lipid rafts upon stimulation (9). The phosphorylated ITAMs serve as docking sites 
for the tyrosine kinase (TK) Syk and adaptor proteins, such as  B-cell linker protein 
(BLNK) (10), Shc (11), Grb2 (12), and Gab (13).  The binding of Syk and adaptor 
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proteins to the phosphorylated ITAMs of the BCR recruits them to the BCR surface 
signaling microdomain in the lipid rafts and activates Syk kinase activity (Syk belongs to 
a group of TKs which have Src homology 2 (SH2) domains). BCR–induced activation of 
Lyn and Syk is required for the activation of Burtons tyrosine kinase (Btk), a Tec family 
protein tyrosine kinase (14). Btk and Syk work in concert for optimal phospholipase C 
gamma (PLC γ) activation (14, 15). Btk activation is also dependent on the 
phosphoinositide 3 kinase (PI-3K)-induced production of phosphatidylinositol 3,4,5-
trisphosphate (PIP3) from phosphatidylinositol 4,5-bisphosphate (PIP2) (16).  PI-3K is 
itself activated by recruitment to the CD19 co-receptor during BCR signaling (17). The 
binding of PH (Pleckstrin Homology) domain of Btk to PIP3 enables Btk recruitment to 
the BCR surface signaling microdomain where it is phosphorylated by Lyn. Failure in 
binding PIP3 due to mutations in the PH domain of Btk leads to defects in Btk activation 
and abnormalities in BCR signaling, consequently resulting in humoral immune 
deficiency (18).   Adaptor protein BLNK (B cell linker protein) is phosphorylated by Syk, 
and This phosphorylation generates docking motifs for SH2-containing proteins like Vav, 
Grb2 and PLC γ2 (10). BLNK, in concert with Btk, activates PLC γ2.  PLC γ cleaves 
phosphatidylinositol bisphosphate (PIP2) to diacylglycerol (DAG) and inositol 
trisphosphate (IP3).  IP3 triggers the release of calcium from the endoplasmic reticulum, 
and increases calcium influx.  DAG in concert with calcium activates protein kinase C 
which, in turn, activates nuclear factor kappa B (NF-κB) by phosphorylating the Inhibitor 
of κB Kinase (IΚK) (19) .  Calcium also activates calcineurin which, in turn, activates 
nuclear factor of activation of T cells (NFAT). NF-κB and NFAT are transcription factors 
that play major roles in B-cell activation (20). Upon activation through BLNK, Vav and 
 3
 
Grb2/SOS (guanine exchange factors) activate Rho and Ras family GTPases, 
respectively. Activated Ras initiates the Raf/MEKK pathway which results in the 
eventual activation of MAP kinase ERK (21) while activation of Rho-family GTPase Rac 
leads to activation of MAP kinases JNK and P38 (22-25).  The eventual goal of these 
kinases is to phosphorylate a number of transcription factors that regulate expression of 
genes involved in cell survival and proliferation. ERK is responsible for phosphorylating 
Elk-1 and c-myc (26), JNK phosphorylates c-Jun and activating transcription factor 2 
(ATF-2) (24), while P38 phosphorylates ATF-2  (27).   
 
There is a group of molecules that exerts regulatory roles on BCR signaling. Notable 
among these are CD45 and C-terminal Src tyrosine kinase (Csk). CD45 is a phosphatase 
that prevents hyperphosphorylation of Lyn at its inhibitory tyrosine residue (Y508), 
which represses the kinase (28). Csk on the other hand exerts a seemingly opposite effect. 
It is a kinase that phosphorylates this same tyrosine, inhibiting Lyn activation (29). CD45 
is partitioned away from the lipid raft signaling microdomains formed after BCR 
crosslinking, thus effectively shielding it from acting on Lyn (30), which is located 
within the lipid rafts. In addition, Lyn plays both a positive and negative role in BCR 
signaling. The resting B cells from Lyn-deficient mice have a hyperphosphorylated status 
when compared to B cells from normal mice, and Lyn-deficient mice have increased 
levels of autoantibodies. Lyn generates its inhibitory effect on B-cell signaling by 
phosphorylating Fc gamma receptor IIB (FcγRIIB) and CD22 on their ITIMs 
(Immunoreceptor tyrosine based inhibitory motifs). When FcγRIIB and BCR are co-
ligated by antibody-antigen complexes, the ITIMs of FcγRIIB are phosphorylated by 
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Lyn, which enables them to recruit a phosphatase called SHIP (SH2-containing inositol 
5` phosphatase (31).  SHIP is able to block PIP3 production by hydrolyzing it to PIP2 
subsequently inhibiting BCR signaling and B cell activation (32). 
1.3 BCR-mediated antigen processing and presentation 
When B cells encounter antigens in the body, the antigens are likely to be present in low 
concentrations, and the number of B cells specific for each antigen is limited.  
Fortunately, the BCR has adapted to overcome this problem by increasing its rate of 
internalization once it encounters an antigen that is able to crosslink to multiple BCRs.  
BCR endocytosis occurs primarily by clathrin-mediated endocytosis (CME) (33), 
although it may be mediated by other forms of endocytosis such as macropinocytosis. In 
the absence of antigens, the BCR is constitutively internalized into early endosomes and a 
large fraction recycles back to the cell surface (8). Following the crosslinking of the BCR 
with its cognate antigen, signaling cascades lead to an increase in the internalization rate 
of the BCR.  BCR crosslinking also efficiently targets the BCR to the late endosomes 
(34).   Additionally, crosslinking induces a reorganization of the actin cytoskeleton, 
which is required for the internalization and movement of the BCR into specialized late 
endosomal compartments (35).  In the late endosome, the internalized antigens are 
fragmented into peptides by proteases that are activated by the acidic environment of the 
endosomes. The resulting peptides are loaded on to major histocompatibility complex 
(MHC) class II molecules for presentation of the complex at the surface of B cells (35).  
The recognition by T cells of MHC class II-presented antigen on the B-cell surface
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FIGURE 1.1. Structure of the BCR complex 
BCR complex is composed of a membrane-bound immunoglobulin that is responsible for 
antigen binding and an Igα/Igβ heterodimer that is responsible for signal propagation. 
Membrane immunoglobulin is non-covalently associated with the Igα/Igβ heterodimer.  
The Igα/Igβ heterodimer contains ITAMs whose tyrosine is phosphorylated following 












initiates a T cell-dependent antibody response.   
 
1.4 The role of signaling in the intracellular trafficking of the BCR  
Recent evidence has shown that the signaling and antigen processing functions of the 
BCR may be linked.  While the BCR internalizes constitutively at a low rate, BCR 
crosslinking by multivalent antigens leads to a rapid internalization of the BCR and 
accelerates the transport of the BCR to the MIIC (36). This antigen-induced BCR 
internalization has been shown to be dependent on BCR-triggered signaling cascades. 
Tyrosine kinase inhibitors that block BCR-induced signaling inhibit antigen-induced 
BCR internalization (37). In addition, the Src kinase Lyn, which is activated following 
BCR crosslinking, was also found to be required for BCR internalization (38).  A study 
from our lab, in collaboration with Dr. Francis Brodsky, showed that crosslinking the 
BCR induces the recruitment of clathrin to the plasma membrane and BCR-containing 
vesicles, and the Src-kinase inhibitor PP2 blocks this recruitment (33).  The 
phosphorylation of clathrin in lipid rafts by Src-kinases following BCR crosslinking is 
required for BCR internalization, which was demonstrated by inhibition of clathrin 
phosphorylation and BCR internalization by the disruption of lipid rafts.  Our lab 
previously showed that low valency antigens induce a rapid internalization of the BCR 
and a transient protein tyrosine phosphorylation.  However, high valency antigens reduce 
BCR internalization, extend the residency of the BCR on the cell surface, and increase 
the level of BCR signaling (34).  These results show that BCR signals and BCR 




The intracellular trafficking of the BCR seems to also be regulated by BCR signaling. 
Prior to BCR crosslinking, the BCR constitutively traffics to the early endosomes from 
where it recycles to the plasma membrane. After crosslinking by an antigen, the BCR is 
targeted from the early endosomes to the late endosomes (39). The targeting of the BCR 
to late endosomes is disrupted by Src kinase inhibitors that disrupt BCR crosslinking 
induced signaling (40), emphasizing the need for BCR signaling to target antigen-BCR 
complexes to the late endosomes.  Using chimeric receptors our lab and a number of 
others have also shown the importance of Igα/Igβ complex in BCR trafficking to the late 
endosomes following BCR crosslinking (41-43). Specifically, mutating the tyrosines in 
the ITAMs of Igα/Igβ led to defects in BCR trafficking to late endosomes (43), further 
indicating that BCR signaling is important for BCR trafficking to the late endosomes.  
 
1.5 Clathrin-mediated endocytosis 
Clathrin-mediated endocytosis (CME) is initiated when adaptor proteins recognize and 
bind to internalization motifs on the cytoplasmic tails of receptors for various cargos. 
There are two main classes of adaptor molecules that bind to internalization motifs; 
tetrameric AP-2 adaptors, and monomeric adaptors such as Dab2 and Epsin (44). The µ2 
subunit of AP-2 interacts with YXXφ internalization motifs on the cytoplasmic tail of 
receptors (45). Dab2 recognizes FXNPXY internalization signals (46) while Epsin 
recognizes polyubiquitination signals via ubiquitin-interacting motifs (47). Recruited 
adaptor proteins bind and sequester cargo receptors while simultaneously binding PIP2 
on the plasma membrane (48). After binding of AP-2 to the appropriate cargo receptor, 
clathrin is recruited to the region. Once the clathrin coat has assembled on the 
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cytoplasmic side of the plasma membrane, the membrane invaginates to form a coated-
pit. The invagination of the coated pit is driven by changes in lipid composition at the 
membrane, the intrinsic curvature of the clathrin triskelia, as well as forces exerted by the 
cytoskeleton (49). Notable among proteins involved at this stage are the Bar domain-
containing proteins endophilin and amphiphysin. Endophilin can alter lipid compositions 
at the cell membrane via acyl transferase activity and bind dynamin during endocytic 
processes (50, 51). Amphiphysin also binds dynamin and, in addition, binds to AP-2 and 
clathrin (44, 51). It plays a major role in recruiting dynamin to endocytic vesicles during 
CME (52-54). Dynamin provides the signal and force that pinches off the coated-pit from 
the cell membrane.  It is recruited to the nascent clathrin-coated vesicles (CCVs) just 
before the pinch off stage (55). Other proteins that are recruited at this dynamin driven-
scission stage of CME include N-WASP, Arp2/3 (56), actin (55) and synaptojanin (57). 
Once the CCVs have pinched off, they shed their clathrin coats due to the activity of 
Hsc70, an ATPase recruited to the CCVs (58). Following the uncoating stage, the 
vesicles fuse with other vesicles to form early endosomes (55).  
 
1.6 A role for the actin cytoskeleton during clathrin-mediated endocytosis 
Initial evidence for the role of actin in endocytosis came from genetic studies of yeast by 
a number of groups (59). Mutations in ACT1, the gene that encodes yeast actin, were 
among the first to be identified as directly impacting the endocytosis of α-factor (a small 
peptide secreted by yeast during mating) (60). Subsequently, researchers have identified a 
number of actin-related, actin-binding and actin-regulating proteins that are also involved 
in yeast endocytosis, and many of these proteins have homologues in mammalian cells 
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(59), further indicating an essential role for the actin cytoskeleton in regulating 
endocytosis.  
 
Additional evidence for the role of actin in endocytosis came from the studies of actin 
cytoskeleton-disrupting agents. Apodaca et al. reported that cytochalasin-D (CD), which 
binds to the barbed end of F-actin and disrupts actin filaments, inhibits apical endocytosis 
in polarized epithelial cells but has no detectable effect on basolateral endocytosis (61).  
Fujimoto et al. studied the effect of different actin-perturbing drugs on the endocytosis of 
transferrin and showed that the involvement of the actin cytoskeleton in CME is 
dependent on cell type and growth conditions (62).  There are a number of endocytic 
pathways in mammalian cells, including the clathrin-mediated endocytosis, the caveolar 
pathway, a clathrin and caveolae-independent pathway, macropinocytois and 
phagocytosis (59).  A role for the actin cytoskeleton has been determined in most of these 
pathways (63, 64), and localized polymerization has been shown at sites of caveolae-
mediated endocytosis (65, 66), clathrin mediated endocytosis (CME) (55), 
macropinocytosis (67) and phagocytosis (68) . 
 
The interaction of actin-binding proteins with proteins involved in CME, as well as the 
effect of actin-regulating proteins on CME has also been used to implicate the actin 
cytoskeleton in CME.  A common structural property of proteins that link the actin 
cytoskeleton to endocytosis is their multiple protein-protein interaction domains, which 
provides them with the potential to bind both F-actin and proteins from the endocytic 
machinery.  Cortactin (69) and mammalian actin binding protein 1 (Abp1) (70) bind both 
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F-actin and dynamin during endocytosis. Huntington-interacting protein 1 (Hip1R) binds 
to both clathrin and F-actin (71, 72), while syndapins can bind to both N-WASP (an actin 
nucleation-promoting factor that stimulates Arp2/3 activity (73))  and dynamin (74-76) 
(Fig. 1.2). Tsujita et al describe a group of proteins called pombe cdc 15 homology 
family (PCH), such as formin-binding protein 17 (FBP17). These proteins were shown to 
bind to phosphatidylserine and PIP2 in membranes, where they help to deform the 
membrane during endocytosis. They were also shown to bind to dynamin and recruit and 
activate N-WASP at the plasma membrane, serving as a link between the endocytosis 
machinery and the actin cytoskeleton (52). It has recently been shown that another 
protein, sorting nexin 9 (SNX9), simultaneously binds to dynamin and N-WASP and 
stimulates Arp2/3-mediated actin assembly, providing another link between the actin 
cytoskeleton and the endocytosis machinery (77, 78). Buss et al. showed that Myosin IV 
colocalized with clathrin-coated vesicles and binds AP-2 in-vitro. Overexpressing the tail 
region of myosin IV blocked transferrin endocytosis in fibroblasts (79).  Myosin IV 
belongs to a group of proteins that move along actin filaments and help in movement of 
membrane vesicles within the cytoplasm (80); this could help link the actin cytoskeleton 
to the inward movement of CCV.  It is likely that more protein linkers between the actin 




FIGURE 1.2. Steps during CME and possible links to actin 
Clathrin-mediated endocytosis is initiated when adaptor molecules bind to internalization 
motifs in the cytoplasmic tail of receptors. This is followed by the recruitment of the 
clathrin and the formation of clathrin-coated pits. Hip1R binds to clathrin and F-actin and 
may help coordinate the interaction of actin with clathrin at this stage. Dynamin is 
recruited to the vesicles and is important for the scission of the nascent vesicle from the 
plasma membrane. Numerous actin-binding proteins that bind the PRD of dynamin may 
be responsible for linking the actin cytoskeleton to dynamin at this stage. Vesicle 
uncoating is stimulated by the ATPase activity of Hsc70 which is recruited to the vesicle 
by auxilin (which binds membrane phospholipids). Uncoated vesicles are able to fuse 
with other vesicles and be transported to various destinations by interactions with the 
microtubule network. Interactions between the actin cytoskeleton and microtubule motor 
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1.7 Regulation of the actin cytoskeleton 
The regulation of dynamic actin networks by extracellular signals has been extensively 
studied during the last decade and has been shown to be largely mediated through the 
Rho family of GTPases.  Rho GTPases (specifically Cdc42, Rac1 and RhoA) are 
activated in response to a variety of extracellular signals (73). The activation of these 
GTPases in many cases leads to the activation of the Arp2/3 complex, which in turn 
regulates actin polymerization. The Arp2/3 complex is required to drive de novo actin 
nucleation, since forming new actin filaments from actin monomers is energetically 
unfavorable (81). However, the activity of the Arp2/3 complex itself is low without the 
help of nucleation-promoting factors (NPFs). Examples of NPFs include WASP, N-
WASP and WAVE. Rho GTPases are linked to the Arp2/3 complex via these NPFs (81).  
 
How receptor activation leads to varied responses by the actin cytoskeleton is not yet 
fully understood, but there is evidence that the activation of different Rho GTPases help 
to generate these varied responses. RhoA helps regulate the formation of stress fibers, 
Rac1 regulates lamellipodia formation, and Cdc42 regulates filopodia formation (69, 73). 
The small GTPases that are involved in directly regulating the actin cytoskeleton during 
endocytosis are not yet known, although a role had been described for Rac and Rho 
whose mutants were shown to block endocytosis of transferrin (82) and low density 
lipoproteins (83).  
 
A number of groups, including our own, have shown that BCR crosslinking can create 
dynamic changes in the actin cytoskeleton (22, 35, 84-87).  Hao et al, showed that the 
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actin cytoskeleton undergoes an initial decrease in F-actin levels followed by an increase 
in F-actin levels at localized sites within the cell after BCR crosslinking of DT40 cell 
lines as well as primary splenocytes (87), indicating that BCR crosslinking induces 
dynamic changes in the actin cytoskeleton. Our lab also has shown a similar 
accumulation of F-actin with the BCR after BCR crosslinking (35), however the link 
between the two is yet to be fully elucidated.  Among the potential candidates that could 
link BCR signaling to actin cytoskeletal rearrangements is Bam32 (B-cell adaptor 
molecule of 32 kDa). It contains an N-terminal SH2 domain, C-terminal PH domain, and 
a number of tyrosine residues, one of which has the consensus tyrosine-phosphorylation 
motif (YXXP) (88).  It is regulated by BCR signaling in a PI-3K-dependent manner and 
by NFAT activity (88).  Following BCR crosslinking, Bam32 is recruited to the plasma 
membrane via the interaction of its PH domain with phosphatidylinositides on the plasma 
membrane (88). Bam32 also regulates the reorganization of the actin cytoskeleton by 
activating Rac1 in response to the BCR crosslinking (85), indicating that Bam32 might 
serve to link signals generated during BCR signaling to the reorganization of the actin 
cytoskeleton following BCR crosslinking. Not surprisingly, Bam32 knockout mice had a 
marked decrease in the rate of BCR internalization, probably due to defects in the BCR 
induced reorganization of the actin cytoskeleton (86).  In support of this, preliminary data 
from our lab shows BCR signaling-dependent activation of Vav, the GEF of Rho-family 
GTPases and WASP, an actin nucleation promoting factor (S. Sharma, unpublished 
observations). The activation of Bam32, Vav and WASP by BCR crosslinking provides 
further evidence for a connection between BCR signaling and the actin cytoskeleton. 
Vascotto et al. have recently provided further evidence for how BCR signaling might 
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regulate the actin dependent trafficking of the BCR. In one study, they observed that 
myosin II, an actin motor protein, is regulated by BCR signaling and is required for the 
interaction of BCR internalized antigens and MHC class II molecules in late endosomes. 
Pharmacologic inhibition or siRNA depletion of Myosin II in splenic B cells led to 
defects in antigen presentation and activation of T cells (89). The same group showed 
that BCR crosslinking-induced actin reorganization was drastically altered, and the 
trafficking of the BCR into late endosomes is inhibited in a Syk-deficient B cells line 
(84). These further indicated a three way connection between the actin cytoskeleton, BCR 
signaling, and antigen transport pathways.  
 
1.8 The actin cytoskeleton and the intracellular trafficking of the BCR 
BCR internalization is dependent on the actin cytoskeleton (35). Work in our lab showed 
that Cytochalasin D (CD), an actin disrupter, Latrunculin, an actin depolymerizer, and 
Jasplakinolide, an F-actin stabilizer, inhibited the antigen-enhanced internalization of the 
BCR.  In contrast, constitutive BCR internalization was not affected by CD treatment, 
implying that actin involvement in BCR internalization is regulated by signals generated 
by BCR crosslinking (35). In CD-treated cells, cortical actin was visualized as reduced 
patches close to the plasma membrane that colocalized with BCR, implying that the BCR 
was trapped in vesicles that were associated with the actin cytoskeleton. Electron 
microscopy studies showed that the BCR accumulated in elongated clathrin-coated pits in 
CD-treated cells, indicating that BCR-containing clathrin-coated pits failed to pinch off.  
An interesting finding was the fact that, unlike previous reports that showed that CD had 
an inhibitory effect on BCR signaling measured by observing of proliferation (actin is 
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required for cytokinesis during proliferation and this is not a BCR signaling mediated 
defect) (90),  we observed an elevation of phosphorylation after BCR stimulation in CD-
treated cells compared to untreated cells. Taken together, these results show that the actin 
cytoskeleton is important for the rapid internalization of the BCR following antigen 
crosslinking, however, the mechanism remains to be elucidated. 
  
1.9 Dynamin and clathrin-mediated endocytosis 
Dynamin is a 100 kDa GTPase that is required for pinching off of coated pits formed at 
the surface of the plasma membrane.  It consists of four main domains, an N-terminal 
GTPase domain, a PH domain, a GTPase effector domain (GED,) and a C-terminal PRD 
(91).  The GTPase of dynamin has a higher GTP hydrolysis activity than small GTPases 
such as Ras(91). Its GTPase activity is greatly enhanced (up to 15 fold) by self 
oligomerization, as in the case of dynamin being recruited to nascent clathrin-coated pits, 
where it oligomerizes to form tight spirals that constrict to pinch off of these vesicles (91, 
92). The GED domain regulates dynamin GTPase activity by binding directly to the 
GTPase domain of dynamin.  This was demonstrated by the fact that  addition of the 
GED domain alone induced the assembly of dynamin and increased its GTPase activity 
by 50 fold (93). The PH domain of dynamin is required for binding to PI(4,5)P2 . This 
binding has been shown to be important for dynamin recruitment to the plasma 
membrane, and mutations in the PH domain disrupt receptor-mediated endocytosis (94, 
95). The PRD region contains SH3 domain-binding sites that are defined by the PXXP 
motif (where X stands for any amino acid) and interacts with numerous proteins 
necessary for a variety of cellular processes including clathrin-mediated endocytosis (96).  
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These proteins include amphiphysin (53), endophilin (96), PLCγ (97), Grb (98), Cortactin 
(99), Vav (100), and Abp1(70). The PRD of dynamin is required for the recruitment of 
dynamin to clathrin-coated pits via interactions with the SH3 domain of amphiphysin 
(101).  Amphiphysin may direct dynamin to coated pits by binding to both dynamin and 
the alpha adaptin of AP-2 (102).  Dynamin also binds to endophilin, a protein recruited to 
the plasma membrane during receptor-mediated endocytosis (RME) (96). Endophilin 
converts lysophosphatidic acid (LPA), an inverted cone-shaped lipid, to phosphatidic acid 
(PA), a cone-shaped lipid, inducing plasma membrane curvature during RME (50). In 
addition to interactions between the PH domain of dynamin and the plasma membrane, 
the PRD of dynamin, which interacts with the SH3 domains of amphiphysin and 
endophilin, helps direct the recruitment of dynamin to the plasma membrane during 
RME.   
 
Dynamin is known to be regulated by signaling during RME. The recruitment of 
dynamin1 to the plasma membrane in the neurological synapse upon depolarization of the 
synapse has been shown to be dependent on dynamin dephosphorylation (103). The 
dephosphorylation of dynamin during depolarization of the synapse is mediated by the 
calcium-dependent phosphatase, calcineurin (104). Upon repolarization of the membrane, 
dynamin is phosphorylated by protein kinase C (PKC) and relocates to the cytosol (105). 
Ahn et al. showed that dynamin 2 can also be tyrosine phosphorylated at positions 231 
and 597 by Src kinases in response to β adrenergic stimulation, and this phosphorylation 
was shown to be important for the internalization of the β2 adrenergic receptor (106). 
During internalization of the FcγRI in mast cells, dynamin 2 is dephosphorylated in 
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response to the aggregation of FcγRI, and this aggregation enhanced the rapid 
internalization of the FcγRI via CME (107). It is unclear whether dynamin is 
phosphorylated during BCR crosslinking induced signaling events. Previous studies 
carried out in our lab have, however, shown that dynamin 2 is recruited to the cell surface 
upon BCR crosslinking and that this recruitment is inhibited by Src kinase inhibitors (B. 
Brown, unpublished observations), implying that the function of dynamin 2 is regulated 
by Src kinases in B cells. In contrast, a recent study reported that dynamin was not 
phosphorylated in T cells following TCR activation (100), implying that the function of 
dynamin is regulated by different mechanisms in different types of cells.  
 
1.10 The role of dynamin in linking the actin cytoskeleton to the 
endocytosis machinery 
Previous studies have revealed that dynamin may provide a major link between the 
endocytosis machinery and the actin cytoskeleton (63) (Fig. 1.3). A number of actin-
binding proteins have been shown to have the ability to bind to the PRD of dynamin via 
their SH3 domains. Examples of such proteins include cortactin that binds and activates 
the Arp2/3 complex (108), syndapins that interact with N-WASP (74, 76), profilin that 
binds to actin monomers and promotes ATP exchange on monomeric actin, facilitating 
filament elongation, and also binds to clathrin (109), and Abp1 that binds F-Actin (70).  
In addition to serving as a link between the endocytic machinery and the actin 
cytoskeleton, dynamin is suggested to have a role in linking extracellular signals to the 
actin cytoskeleton. Dynamin has been shown to regulate the subcellular localization of 
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Rac to the leading edge of lamellipodia (F actin-based structures), and induces cell 
spreading in response to PDGF in rat fibroblasts and NIH3T3 cells (110). It was shown in 
these experiments that dynamin knockdown using siRNA as well as dominant negative 
transfections of a Dynamin K44A (a mutation that inactivates the GTPase of dynamin) 
were able to mislocalize Rac and hence interfere with Rac-induced actin reorganization at 
the leading edge of lamellipodia.  Dynamin was also shown to be involved in the 
reorganization of the actin cytoskeleton at the immunological synapse formed between a 
T cell and an antigen-presenting cell (APC) (100). In T cells, dynamin was shown to be 
important for recruiting Vav (100). Vav is a GEF that activates Cdc42, which regulates 
WASP, a key activator of actin polymerization in the T cell synapse (111). Further 
evidence for the regulatory role of dynamin in the actin cytoskeleton was provided by 
studies of actin pedestal formation induced by enteropathogenic E-coli invasion of 
epithelial cells. Interaction of the bacteria with the epithelium generates actin-rich 
pedestals by bacteria-secreted factors. Bacteria-induced actin pedestal formation was 
abolished when dynamin expression was knocked down using siRNA (112), implicating 
dynamin in the regulation of this actin-based structure.  
 
1.11 Abp1 in Endocytosis 
Mammalian actin-binding protein 1 (Abp1), which is also known as SH3P7 and HIP-55, 
was discovered in a screen for novel proteins containing SH3 domains (113).  Abp1 
belongs to the debrin family of actin-binding proteins (114). It is a 55 kDa 
phosphoprotein with multiple sequence motifs for protein-protein interactions (114),  
including two N-terminal actin-binding domains, a PRD, and a C-terminal SH3 domain.
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FIGURE 1.3. Dynamin is a major link between CME and actin 
Dynamin is recruited to nascent clathrin coated vesicles (CCVs) by interactions between 
its PH domain and PI(4,5)P at the plasma membrane as well as interactions between its 
PRD with amphiphysin (binds AP-2) and endophilin (binds lipids at the plasma 
membrane). The PRD of dynamin mediates the interaction between dynamin and the 
actin cytoskeleton by binding to a number of SH3 domain-containing actin-binding 
proteins (Abp1, cortactin, profiling, and syndapins). 
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Abp1 was first discovered in yeast and originally characterized as a protein important in 
actin-dependent endocytosis (59). Sequence analysis revealed that mammalian Abp1 had 
a significant sequence homology to yeast Abp1 (21% in the actin-binding domain and 
40% in the SH3 domain) (115). Yeast Abp1 has the ability to bind to the Arp2/3 complex 
and increase the affinity of this complex for F-actin. Abp1 binds directly to F-actin in 
mammalian systems (114). Abp1 is expressed in most tissues of the mouse that have been 
tested, including testis, spleen, brain, thymus, heart, and lungs, while very little was 
detected in ovaries and muscle (114). In addition, a number of human cell lines, including 
Ramos B cells and Jurkat, express the human homolog of Abp1 (114). Mammalian Abp1 
lacks the acidic motif required for interacting with the Arp2/3 complex (115, 116), and 
may, therefore, not be directly involved in regulating the actin cytoskeleton. However, 
Abp1 was recently shown to interact with and activate N-WASP with the help of Cdc42 
in neuronal cells (117), implying that at least in some mammalian systems, Abp1 may be 
involved in actin regulation.  
 
Abp1 is able to interact with the PRD of dynamin via its SH3 domain, and this interaction 
has been shown to be important for receptor-mediated endocytosis of transferrin (70). 
The ability of Abp1 to bind to both F-actin and dynamin implies that it could provide a 
physical link between the endocytic machinery and the actin cytoskeleton.  Abp1 has 
been shown to be phosphorylated at tyrosines 337 and 347 of the PRD by Syk and Lyn in 
vitro upon BCR crosslinking (114).  These findings led us to hypothesize that Abp1 plays 
a role in linking the BCR signaling and endocytosis pathway to the actin cytoskeleton. 
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FIGURE 1.4. Actin binding protein 1 (Abp1) and its interactions 
Abp1 is a 55 kDa phosphoprotein with multiple sequence motifs for protein-protein 
interactions, including two N-terminal actin-binding domains, a PRD, and a C-terminal 
SH3 domain. The PRD of Abp1 contains two consensus tyrosine phosphorylation sites 
which are substrates for Src kinases in B cells. The SH3 domain of Abp1 has been shown 
to bind dynamin and facilitate the internalization of transferrin as well as the binding of 
HPK1 (a MAP4K in the JNK activation pathway) in T cells and hence, serves an adaptor 
function in T cell signaling. 













1.12 Role of Abp1 in Lymphocyte activation 
Abp1 (HIP55), was identified as a key regulator of hematopoetic progenitor kinase 1 
(HPK1) in T cells (118, 119). HPK1 belongs to a group of kinases referred to as germinal 
center kinases and a subgroup of the STE20-related proteins (120). HPK1 is a MAP4K 
that is able to activate the c-Jun N-terminal kinase (JNK) pathway by activating MAP3Ks 
that include MEKK1, MLK3, and TAK1 (121). Activation of JNK leads to the 
phosphorylation of c-jun, a component of the AP-1 transcription factor that regulates cell 
proliferation and apoptosis (24). HPK1 was recently shown to be a negative regulator of 
T-cell receptor signaling by inhibiting TCR-mediated production of IL-2 (121). In 293T 
cells, Abp1 was shown to associate with HPK1 in immunoprecipitation studies. This 
interaction was meditated by the binding of the SH3 domain of Abp1 with one of the four 
PRDs of HPK1 and the interaction was shown to be important for JNK activation (118, 
119).   
 
Abp1 is recruited to the T-cell:APC interface in T cells in an antigen-dependent manner 
where it localizes with lipid rafts (122). Abp1 is phosphorylated on tyrosines 334 and 344 
by Zap70 in Jurkat T cells (119). Abp1 is important for TCR-mediated activation of T 
cells.  T cells showed defects in proliferation, cytokine production, and upregulation of 
activation markers, notably CD69, in Abp1-knockout mice (Abp1-/-). Abp1-/- mice 
displayed a marked reduction in humoral immune response to T-dependent antigens 
(123). Defective TCR-induced activation of Lat,  PLCγ1, JNK and HPK1 were also 
observed in Abp1-/- mice (123).  These point to a role for Abp1 in antigen-induced 




The role for Abp1 in the signal transduction of B cells has yet to be studied. The fact that 
it is a substrate for Src kinases, as well as a link to kinases involved in later stages of 
BCR signaling, raises the possibility that Abp1 serves as an adaptor protein that links 
upstream to downstream signaling events of the BCR for B cell activation. The ability of 
Abp1 to interact with the actin cytoskeleton allows it to link the actin cytoskeletal 
dynamics regulated by BCR activation with BCR-mediated signaling events.  
 
1.13 Significance 
In this thesis, I have investigated the interaction between the actin cytoskeleton, BCR 
signaling and antigen processing pathways. I have identified Abp1 and dynamin 2 as 
molecular links between the actin cytoskeleton, BCR signaling and antigen processing 
pathways. I have studied the interrelationship between dynamin and Abp1 and the role of 
these two proteins in regulating BCR-mediated signal transduction and antigen 
processing and presentation. 
 
The internalization, processing, and presentation of antigens, by B cells, is a critical step 
in mounting an effective immune response to pathogens, and this study will provide 
further insights into how this processes are regulated. When the processes are not 
properly regulated, B-cell malfunction may lead to serious consequences. This is 
underscored by a variety of pathological conditions including autoimmune and allergic 
disorders, some of which can be traced to defects in B-cell regulation.  The effector 
function of the B cell is mediated by the BCR, with which it binds antigens. The BCR has 
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two functions, first as an antigen-binding receptor and second as a signal transducer that 
activates the B cell. After binding the antigen the BCR transports it to endosomal 
compartments that enable the processing and presentation of the antigen. The antigen, 
when presented to T cells enables additional signals to be supplied to the B cell by T 
cells. Defects at the stage of antigen processing and presentation or during signal 
transduction can have significant consequences for the immune system either by 
attenuating the immune system or overstimulating the immune system. Both scenarios are 
undesirable events. Understanding both the antigen processing and presentation functions 
of the BCR and the signaling functions of the BCR as well as the links that may exist 
between them will enable us appreciate how these events are regulated. This can help us 




Chapter 2: Actin binding protein 1 regulates BCR-mediated antigen 
processing and presentation in response to BCR activation 
 
2.1 Abstract 
The B cell receptor (BCR) serves as both signal-transducer and antigen-transporter.  
Binding of antigens to the BCR induces signaling cascades and antigen-processing and 
presentation, two essential cellular events for B cell activation.  BCR-initiated signaling 
increases BCR-mediated antigen-processing efficiency by increasing the rate and 
specificity of antigen transport.  Previous studies showed a critical role for the actin 
cytoskeleton in these two processes.  Here we found that actin-binding protein 1 
functioned as an actin-binding adaptor protein, coupling BCR signaling and antigen-
processing pathways with the actin cytoskeleton.  Gene knockout of Abp1 and over-
expression of the SH3 domain of Abp1 inhibited BCR-mediated antigen internalization, 
consequently reducing the rate of antigen transport to processing compartments and the 
efficiency of BCR-mediated antigen-processing and presentation.  BCR activation 
induced tyrosine phosphorylation of Abp1 and translocation of both Abp1 and dynamin 2 
from the cytoplasm to plasma membrane, where they colocalized with the BCR and 
cortical F-actin.  Mutations of the two tyrosine phosphorylation sites of Abp1 and 
depolymerization of the actin cytoskeleton interfered with BCR-induced Abp1 
recruitment to the plasma membrane.  The inhibitory effect of a dynamin PRD deletion 
mutant on the recruitment of Abp1 to the plasma membrane, co-immunoprecipitation of 
dynamin with Abp1, and co-precipitation of Abp1 with GST fusion of the dynamin PRD 
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demonstrate the interaction of Abp1 with dynamin 2.  These results demonstrate that the 
BCR regulates the function of Abp1 by inducing Abp1 phosphorylation and actin 
cytoskeleton rearrangement, and that Abp1 facilitates BCR-mediated antigen-processing 
by simultaneously interacting with dynamin and the actin cytoskeleton.   
2.2 Introduction 
B cell-mediated antibody responses constitute one of the major components of the 
immune system.  B cells are activated through two separate stages of signals, and the B 
cell antigen receptor (BCR) plays an essential role in the generation of both stages of 
signals.  The binding of antigens to the BCR induces signaling cascades that provide the 
first stage signals for B cell activation (14, 124). Subsequently, the BCR internalizes the 
antigens to the endosomal system, where the antigens are processed and loaded onto 
MHC class II molecules.  The interaction between B cells and T cells in the context of 
antigenic peptide-MHC class II complexes triggers the second stage of signals.  The 
induction of affinity maturation and the establishment of B cell memory require both 
stages of signals (125, 126).   
 
The BCR serves as both signal transducer and antigen transporter.  Binding of the BCR to 
multi-valent antigens not only induces signal transduction, but also triggers rapid 
internalization of the BCR and accelerates targeting of the BCR to antigen processing 
compartments (127, 128). The BCR increases the antigen processing and presentation 
efficiency of B cells by increasing the kinetics and specificity of antigen uptake and 
transport to antigen processing compartments (127, 128), allowing B cells to present an 
antigen even when the antigen is sparse.  BCR signaling and antigen 
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processing/presentation functions have been shown to be interrelated.  BCR signaling 
blockage by tyrosine kinase inhibitors (40, 129), mutations of the tyrosine 
phosphorylation sites in the Igα chain of the BCR (43, 130, 131), and loss-function 
mutants for Lyn or Syk (38, 84, 132) inhibit accelerated antigen transport and lower the 
antigen-presenting efficiency of B cells.  Our lab previously showed that crosslinking the 
BCR induced the recruitment of clathrin to the cell surface and BCR-containing vesicles 
and the tyrosine phosphorylation of clathrin in lipid rafts, both of which were required for 
BCR internalization (33).  The exact mechanisms underlying the interaction of BCR 
signaling and antigen transport pathways have not been well studied. 
 
The involvement of the actin cytoskeleton in BCR-mediated activation of B cells has 
long been suggested.  Early studies showed that antigen binding induced the translocation 
of the BCR and tyrosine kinases Lyn and Syk to the detergent-insoluble cytoskeletal 
fractions (133-135), reorganization of the actin cytoskeleton (90, 136-139), and transient 
increases in F-actin levels in B cells (35, 87).  Hao and August recently showed that 
disruption of the actin cytoskeleton altered BCR-induced activation of the MAP kinase 
ERK and transcription factors SRF, NFAT, and NF-κB (87).  We previously 
demonstrated that the dynamic property of the actin cytoskeleton was required for signal-
stimulated BCR internalization.  BCR endocytosis is blocked at the pinching-off step 
during clathrin-coated vesicle formation in the absence of the functional actin 
cytoskeleton (35). Stoddart et al. (140) suggested an actin cytoskeleton-dependent and 
clathrin-independent BCR internalization pathway in DT40 chicken B cells.  It has 
recently been reported that myosin II, an actin motor, is activated upon BCR engagement 
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and facilitates BCR-driven antigen processing and presentation by interacting with MHC 
class II–invariant chain complexes (141).  The findings that the actin cytoskeleton 
undergoes reorganization in response to BCR signaling and this reorganization is 
required for signal-induced BCR internalization suggest a role for the actin cytoskeleton 
in cross talk between BCR signaling and antigen-processing pathways.  
 
Actin-binding protein 1 (Abp1, SH3P7 or HIP-55) is a multi-domain protein that contains 
two independent F-actin-binding domains (ABDs), a proline-rich domain (PRD), and a 
Src homology 3 (SH3) domain (114, 115, 118).  The SH3 domain of Abp1 is closely 
related to the SH3 domain of murine cortactin, an F-actin binding protein and a substrate 
of Src kinase.  Thus, Abp1 is able to simultaneously interact with the actin cytoskeleton 
and molecules of other pathways (70, 118, 142, 143).  Abp1 was first cloned from yeast 
(144) and named Abp1p.  Its mammalian homologue was cloned later by several different 
research groups (114, 115, 118).  Abp1 was found to bind F-actin and be capable of 
directly (in yeast) (116) or indirectly (in mammal) (115, 145) regulating the ability of the 
Arp2/3 complex to assemble branched actin filament networks.  In yeast, Abp1p directly 
interacts with RVS167/amphiphysin, an endocytosis machinery protein, and was 
recruited to cortical actin patches partially coinciding with sites of endocytosis (146).  In 
mammalian cells, Abp1 accumulates in lamellipodia in response to growth factors or the 
expression of dominant-active Rac1 (115) and is involved in transferrin receptor (TfR) 
endocytosis by a direct interaction with dynamin (70), a GTPase that drives the release of 
the nascent clathrin-coated vesicles (91).  The role of Abp1 in TfR internalization was 
further confirmed in Abp1-deficient embryonic fibroblasts (147) and in cells where Abp1 
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was knocked down by siRNA (148).  Recently established Abp1-knockout mice 
exhibited a moderate reduction in synaptic endocytosis and a dramatic defect in the 
reformation of fusion-competent vesicles in synapses of hippocampus neurons (147).  
Abp1-deficiency also caused abnormal structure and function of multiple organs, 
including the spleen, heart and lung in both heterozygous and homozygous mice (147). 
 
In lymphocytes, antigen engagement of the BCR or TCR induces tyrosine 
phosphorylation of Abp1, probably by Lyn, Syk or Zap70 (114, 119).  Abp1 was found to 
be recruited to the immunological synapse of T cells and bind to phosphorylated Zap70 in 
response to TCR stimulation (122).  RNAi knockdown of Abp1 inhibited TCR-induced 
activation of hematopoetic progenitor kinase 1 (HPK1) and the MAP-kinase JNK (118, 
119).  T cells from Abp1-knockout mice showed similar TCR signaling defects (123).  
While T and B cells appeared to develop normally, T cells in Abp1-/- mice exhibited 
reduced T cell proliferation and IL-2 secretion.  These defects were accompanied by 
reduced T cell-dependent antibody responses (123).  While the role of Abp1 in B cells 
has not yet been examined, the data accumulated to date suggest a potential role for Abp1 
in interaction with both antigen receptor signaling and antigen transport pathways.   
 
In this study, we examined the relationship of Abp1 with BCR signaling and antigen 
processing and presentation pathways.  We demonstrate that the BCR regulates the 
function of Abp1 by inducing Abp1 phosphorylation and actin cytoskeleton 
rearrangement, and that Abp1 facilitates BCR-mediated antigen processing by interacting 
with dynamin and the actin cytoskeleton. 
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2.3 Materials and Methods  
2.3.1 Mice, cells and cell culture   
B cell lymphoma A20 IIA1.6 cells (H-2d, IgG2a+, FcγRIIB-) were cultured in DMEM 
supplemented with 10% FBS.  C57BL6 mice which were 6~8 weeks old were purchased 
from Taconic (Hudson, NY).  Abp1 knockout mice (Abp1-/-) were generated and crossed 
into a C57BL/6 background as previously described (123).  To isolate splenic B cells, 
single-cell suspensions of splenocytes were subjected to density-gradient centrifugation 
(2300 x g) in Ficoll (Sigma-Aldrich, St Louis, MO) to obtain mononuclear cells, treated 
with anti-Thy1.2 mAb (BD Biosciences, San Jose, CA) and guinea pig complement 
(Rockland Immunobiochemicals, Gilbertsville, PA) to remove T cells, and panned for 2 h 
to remove monocytes. 
 
2.3.2 DNA constructs and transfection 
The cDNA of myc-tagged full length (myc-Abp1), actin-binding domains (ABDs), PRD-
SH3 domains (PRD-SH3), and SH3 domain (SH3) of Abp1 were cloned into a pRK5 
plasmid as previously described (115).  Mutations of tyrosines 337 and 347 to 
phenylalanine (myc-Abp1 Y337FY347F) were generated using the Stratagene quick 
change site-directed mutagenesis kit (Stratagene, La Jolla, CA) and confirmed by 
sequencing.  DNA constructs were introduced into A20 B cells by electroporation using a 
Nucleofection kit (Amaxa, Gaithersburg, MD).   
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2.3.3 Analysis of the movement of the BCR from the cell surface to late endosomes 
B cells were incubated with Alexa Fluor (AF) 488-conjugated F(ab’)2-goat anti-mouse 
IgG or IgM (Invitrogen, Carlsbad, CA) for 20 min at 4oC to label the surface BCR.  Cells 
were washed and adhered to poly-lysine-coated slides (Sigma-Aldrich) for 40 min at 4oC 
and then chased at 37oC for varying lengths of time to allow for BCR internalization.  At 
the end of each time point, cells were fixed with 4% paraformaldehyde, permeabilized 
with 0.05% saponin, and incubated with a mAb specific for lysosome-associated 
membrane protein 1 (LAMP-1) (ID4B, ATCC, Manassas, VA) and an AF633-conjugated 
secondary antibody.  Myc-Abp1 was detected using Cy3-anti-c-myc mAb (Sigma-
Aldrich).  Endogenous Abp1 was detected using rabbit anti-Abp1 antibody (70) and an 
AF546-conjugated secondary antibody (Invitrogen).  Cells were mounted with gel mount 
(Biomeda, Foster City, CA) and analyzed using a laser-scanning confocal fluorescence 
microscope (LSM 510; Zeiss, Oberkochen, Germany).  For quantitative analysis of 
images, the cellular distribution of the BCR was divided into three different categories:  
the BCR mainly distributed on the cell surface without colocalization with LAMP-1, 
extensively colocalized, and partially colocalized with LAMP-1 at the perinuclear region 
of cells.  Cells were categorized by visual inspection.  Over 100 cells from three 
independent experiments were analyzed for each time point, and the data were plotted as 
percentages of the total number of cells in the images. To quantify the levels of 
colocalization between the BCR and LAMP-1, the correlation coefficients of the staining 




2.3.4 Analysis of BCR internalization 
Splenic B cells were incubated with biotinylated F(ab’)2 fragments of goat anti-mouse 
IgM (20 µg/ml; Jackson ImmunoResearch) for 30 min at 4oC to label the surface BCR. 
After washing off unbound antibodies, cells were chased at 37oC for 0, 2, 5, and 20 min.  
The chase was terminated by adding ice-cold DMEM containing 6 mg/ml BSA.  The 
biotinylated antibodies remaining on the cell surface were stained with PE-streptavidin (5 
µg/ml; Qiagen, Valencia, CA) at 4oC.  The cells were then fixed and analyzed using a 
flow cytometer (FACSCalibur, BD Bioscience).  The data was plotted as a percentage of 
the mean fluorescence intensity of cell-surface PE-streptavidin at time 0.  To 
depolymerize the actin cytoskeleton, cells were treated with 5 μm latrunculin 
(Calbiochem, San Diego, CA) for 30 min at 37oC before the internalization assay, and 
latrunculin was also included in the incubation medium during the internalization assay. 
 
2.3.5 Antigen presentation Assay 
Splenic B cells were incubated sequentially with the following antibodies and reagents at 
4oC.  Anti-CD32/CD16 mAb (BD Biosciences) was used to block FcγII/IIIRs.  A peptide 
(a.a. 52-68) of MHC class II I-E α chain fused with red fluorescence protein (EαRFP) 
was used as the antigen (a gift from Dr. Mark Jenkins, University of Minnesota).  An 
equivalent concentration of rabbit anti-RFP (Rockland Immunochemicals) was used to 
bind to RFP and rabbit anti-mouse IgM (5 µg/ml, Jackson ImmunoResearch) to cross-
link the BCR. Goat anti-rabbit IgG (Fc) (5 µg/ml, Jackson ImmunoResearch) was used to 
target the Eα-RFP-anti-RFP antibody complex to the BCR.  B cells were allowed to 
internalize the antigen-antibody complex for 10 min at 37oC, washed, and incubated at 
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37oC for 14 h.  After washing, cells were incubated with anti-CD32/CD16 mAb and 
biotin-conjugated mAb Y-Ae (eBioscience, San Diego, CA), followed by PE-streptavidin 
to label Eα-I-Ab complexes (149, 150).  Cells were fixed and analyzed using a flow 
cytometer.  The surface expression level of MHC class II was monitored before and after 
the incubation with the antigen-antibody complex using PE-anti-mouse MHC class II 
(Miltenyi Biotec, Auburn, CA) by flow cytometry. 
 
2.3.6 Analysis of cellular distributions of Abp1, F-actin, and dynamin 2 
A20 B cells and splenic B cells were incubated with Cy5-conjugated Fab fragments of 
rabbit anti-mouse IgG+M to label the BCR and activated by F(ab’)2 donkey anti-mouse 
IgG+M (20 μg/ml; Jackson ImmunoResearch). Cells were permeabilized and stained 
with goat-anti-Abp1 antibody for endogenous Abp1, Cy3-anti-myc antibody for 
transfected Abp1, anti-dynamin 2 antibody (BD biosciences), or AF488-phalloidin 
(Invitrogen) for F-actin.  Goat anti-mouse Abp1 antibody was generated by immunization 
of a goat with GST-Abp1 fusion proteins by Alpha Diagnostics International (San 
Antonio, TX) and purified using a protein G-sepharose column. To disrupt the actin 
cytoskeleton, cells were pretreated with 5 μM latrunculin for 30 min at 37oC.  Cells were 
analyzed using a confocal fluorescence microscope.  The recruitment of Abp1 to the cell 
surface was quantified by visually inspecting five randomly selected fields (~100 cells) 
from each of three independent experiments.  Correlation coefficients between the 
staining of Abp1 and BCR in individual cells were determined using the LSM510 
software to quantify the extent of the colocalization. Over 100 cells from two or three 




To further analyze the cellular distribution of Abp1 in relation to dynamin 2, A20 cells 
were co-transfected with plasmids of myc-Abp1 and either GFP-dynamin 2 (GFP-Dyn) 
or GFP-dynamin 2 with its PRD deleted (GFP-∆PRD) (kind gifts from Dr. Mark A. 
McNiven at Mayo Clinic, Rochester, MN). The BCR was labeled using AF633-Fab-goat 
anti-mouse IgG for 15 min at room temperature on polylysine coated slides. The cells 
were then activated with rabbit anti-mouse IgG (20 µg/ml) for 5 and 30 min at 37oC, 
followed by fixation and permeabilization. Transfected Abp1was stained with Cy3-anti-
myc antibody, and cells were analyzed using a confocal fluorescence microscope. 
Correlation coefficients between the staining of Abp1 and GFP-Dyn at the cell surface 
area were determined using the LSM510 software.  Over 30 cells from three independent 
experiments were analyzed for each condition.  
 
2.3.7 Analysis of tyrosine phosphorylation of Abp1 
 
Untransfected A20 cells and A20 cells transfected with plasmids myc-Abp1 were 
activated by crosslinking the BCR with goat anti-mouse IgG (20 µg/ml) for indicated 
times and lysed in a lysis buffer containing 0.5% Triton X100, 20 mM Tris-HCl, pH 7.5, 
150 mM NaCl, 1 mM MgCl2, 1 mM EGTA, 1 mM Na3VO4, and protease inhibitors 
(Sigma).  Lysates were subjected to immunoprecipitation using rabbit-anti-Abp1 
antibody for endogenous Abp1 and anti-myc mAb (Bethyl Labs, Montgomery, TX) for 
transfected Abp1.  The immunoprecipitates were analyzed by SDS-PAGE and Western 
blotting, probing with anti-phospho-tyrosine mAb (4G10, Upstate Biotech, Lake Placid, 
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NY).  The blots were stripped and reblotted with guinea pig anti-Abp1 (115) or anti-myc 
antibodies. 
 
2.3.8 Co-immunoprecipitation and coprecipitation of Abp1 and dynamin 2 
A20 cells were activated with rabbit anti-mouse IgG for indicated times at 37oC and lysed 
with the 0.5% Triton X100 lysis buffer.  The lysates were subjected to 
immunoprecipitation using goat-anti-Abp1 antibody and protein G sepharose beads, and 
the immunoprecipitates were analyzed using SDS-PAGE and Western blotting.  The 
presence of dynamin 2 in the anti-Abp1 immunoprecipitates was detected using anti-
dynamin 2 antibody (BD Biosciences), and Abp1 was detected using guinea pig anti-
Abp1 antibody.   
 
The DNA construct of GST-dynamin PRD fusion protein (GST-dynamin PRD, a gift 
from Dr. Mark McNiven, Mayo Clinic, Minnesota) was expressed in the E. coli BL21 
strain.  The bacteria were grown at 37oC in LB medium supplemented with 100 µg/ml 
ampicillin until OD600 = 1.0.  The synthesis of the fusion protein was induced by 1.0 mM 
IPTG (US Biological, Swampscott, MA) for 3 h.  Cells were harvested, washed and lysed 
using a lysis buffer (140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, 
pH 7.4, 1 mg/ml lysozyme, and protease inhibitor cocktail) and three freeze-thaw cycles.  
The lysate was centrifuged at 70,000 x g for 25 min at 4oC, and supernatant was loaded 
onto a GSTrap FF column (GE Healthcare, Uppsala, Sweden).  The column was washed 
with PBS and stored in PBS containing 0.05% Sodium Azide.  A20 cells transfected with 
either myc-Abp1 or myc-Abp1-ABDs were activated with goat anti-mouse IgG (20 
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µg/ml) for indicated times at 37oC and lysed with the Triton X100 lysis buffer.  The 
lysates were incubated with GST-dynamin PRD beads overnight, and the precipitates 
were analyzed using SDS-PAGE and Western blotting.  The presence of myc-Abp1 in the 
precipitates was detected using anti-myc mAb (BD Biosciences) and a HRP-conjugated 
secondary antibody. 
2.3.9 Statistics 
P values were generally obtained by conducting 2 tailed, paired students t test on data 
from at least 3 independent experiments. To determine the significance between data of 
correlation coefficients, the mean correlation coefficients of six individual fields 
randomly selected from at least two independent experiments were acquired, and p values 
were determined using the 2 tailed, paired students t test.  
 
2.4 Results 
2.4.1 Abp1 is required for BCR-mediated antigen uptake  
To test whether Abp1 plays a role in BCR-mediated antigen transport, the functions of 
Abp1 were disrupted by gene knockout and over-expression of dominant negative 
mutants.  The Abp1 knockout mouse model was previously developed by Han et al. 
(123), and the deletion of the Abp1 gene (Fig. 2.1A, top panel) and the absence of Abp1 
protein expression (Fig. 2.1A, bottom panels) were confirmed by PCR analyses of 
genomic DNA and Western blot analyses of splenic B cell lysates.  The movement of the 
BCR from the cell surface to the LAMP-1+ compartment was followed by 
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immunofluorescence microscopy (Fig. 2.1B).  Based on the cellular distribution pattern 
of the BCR and LAMP-1, cells were categorized into three groups: (1) BCR colocalizing 
with LAMP-1 extensively in the perinuclear region, (2) BCR remaining on the cell 
surface and periphery with no significant colocalization with LAMP-1, and (3) BCR 
partially colocalizing with LAMP-1.  The numbers of cells in these three categories were 
plotted as percentages of the total number of cells in the field (Fig. 2.1C).  After a 30 min 
chase at 37oC, the surface labeled BCR was extensively colocalized with the LAMP-1 in 
over 60% of wt splenic B cells, compared to just ~30% of Abp1-/- splenic B cells (Fig. 
2.1B-C).  In more than 60% of Abp1-/- splenic B cells, the BCR remained at the cell 
surface and periphery after a 30 min chase (Fig. 2.1B-C), indicating that Abp1-deficiency 
dramatically slowed BCR-mediated antigen transport.  This is further supported by the 
quantitative analysis of colocalization between the BCR and LAMP-1 staining. While 
BCR crosslinking increased the correlation coefficients between the BCR and LAMP-1 
in both wt and Abp1-/- splenic B cells, the increase in wt B cells was significantly greater 
than that in Abp1-/- B cells (Fig. 2.1D).  To analyze the effect of Abp1-deficiency on the 
kinetics of BCR internalization, the surface BCR of splenic B cells from both wt and 
Abp1-/- mice were labeled with biotin-F(ab’)2-anti-mouse IgM at 4°C and chased for 0, 2, 
5 and 20 min at 37°C.  Biotin-anti-mouse IgM remaining at the cell surface after the 
chase was detected with PE-streptavidin and quantified using flow cytometry.  As shown 
in Fig. 2.1E, Abp1-deficiency significantly decreased the kinetics of BCR internalization. 
Furthermore, Abp1-deficiency and F-actin depolymerization by latrunculin-treatment 
inhibited BCR internalization to a similar extent. These data demonstrate that Abp1-
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deficiency inhibits BCR-mediated antigen uptake, consequently reducing the rate of 
antigen transport to the antigen processing compartment. 
 
To determine which domain of Abp1 is important for BCR-mediated antigen transport, 
we introduced plasmids of myc-tagged full length Abp1 (myc-Abp1), two actin binding 
domains (ABDs), myc-Abp1 with two tyrosine phosphorylation sites mutated 
(Y337FY347F), PRD and SH3 domains (PRD-SH3), or SH3 domain (SH3) of Abp1 (70) 
into A20 B cells by transient transfection (Fig. 2.2A).  The movement of the BCR from 
the cell surface to late endosomes was analyzed using immunofluorescence microscopy.  
After 30 min chase, the BCR in more than 50% of cells that underwent electroporation 
but did not express proteins from transfected plasmids colocalized with LAMP-1 
extensively in the perinuclear location (Fig. 2.2A-B).  Overexpression of full-length myc-
Abp1, myc-Abp1 ABDs, or myc-Abp1 Y337FY347F did not alter the extent of the 
colocalization between the BCR and LAMP-1 (Fig. 2.2Aa-Al and 2B), indicating that 
they had no significant effect on the movement of the BCR to the LAMP-1+ 
compartment.  In contrast, only 10-20% of cells that expressed myc-Abp1 PRD-SH3 or 
myc-Abp1 SH3 showed colocalization of the BCR with LAMP-1, and in ~70% of those 
cells, the BCR remained on the cell surface and periphery, displaying no significant 
colocalization with LAMP-1 after the 30 min chase (Fig. 2.2Am-At and 2.2B).  This 
indicates that over expression of the SH3 domain of Abp1 inhibits the movement of the 
BCR from the cell surface into late endosomes and suggests a role for the SH3 domain of 
Abp1 in BCR-mediated antigen transport.  
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FIGURE 2.1. Abp1 gene knockout reduces the rates of BCR internalization and 
movement from the plasma membrane to late endosomes.   
(A) Abp1 gene knockout in mice was confirmed using PCR (top panel) and Western blot 
(bottom panel).  (B) Splenic B cells from wt and Abp1-/- mice were incubated with Alexa 
Fluor (AF)-488-F(ab’)2-goat anti-mouse IgM at 4oC for labeling and crosslinking the 
surface BCR and then chased at 37oC for 30 min.  Cells were fixed, permeabilized, and 
labeled with anti-Abp1, anti-LAMP-1, and fluorochrome-conjugated secondary 
antibodies.  Cells were analyzed using a confocal fluorescence microscope. Shown are 
representative images of three independent experiments.  Bar, 5 μm.  (C) Cells were 
categorized by visual inspection into three different categories: cells showing extensive 
colocalization, no colocalization, and partial colocalization between the BCR and LAMP-
1.  Cells from more than ten randomly selected fields containing at least 15 cells per field 
from three independent experiments were inspected.  Shown are the average percentages 
(±S.D.) of cells in each of the three categories.  **, p<0.01. (D) Shown are correlation 
coefficients between the staining of the BCR and LAMP1 in ~100 individual cells of 
three independent experiments. Black bars represent mean correlation coefficients. *, 
p<0.05, paired 2 tailed student t test of mean correlation coefficient from six fields of 
view from three independent experiments. (E) The surface BCR was labeled with biotin-
F(ab’)2-goat anti-mouse IgM at 4oC and chased at 37oC for indicated times.  Biotin-anti-
mouse IgM left on the surface after the chase was detected by PE-streptavidin and 
quantified using a FACS Calibur.  For latrunculin (LAT) treatment, cells were incubated 
with 5 μM latrunculin before and during the analysis. The data were plotted as the 
 41
 
percentages of the surface-labeled BCR at time 0.  Shown are the averages (±S.D.) of 
three independent experiments. *, p<0.05, **, p<0.01. 
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FIGURE 2.2. The effect of over expression of Abp1 domains and mutants on the 
movement of the BCR from the cell surface to late endosomes.  
 (A) B cell lymphoma A20 cells were transiently transfected with myc tagged full-length 
protein of Abp1 (Abp1), Abp1 with its two tyrosine phosphorylation sites mutated 
(Y337FY347F), actin-binding domains (ABDs), PRD and/or SH3 domains (PRD-SH3 
and SH3) of Abp1.  Twenty-four hours after transfection, cells were labeled with AF488 
goat anti-mouse IgG for 20 min at 4oC and chased for 30 min at 37oC.  Cells were fixed, 
permeabilized, and labeled with anti-myc antibody for myc-Abp1 and anti-LAMP-1 mAb 
for late endosomes.  Arrows indicate cells expressing transfected proteins.  Bar, 10 μm.  
(B) Cells were categorized by visual inspection into three different categories as 
described in Fig. 2.1.  Shown are the average percentages (±S.D.) of cells in each of the 
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2.4.2 B cells with Abp1-deficiency are defective in BCR-mediated antigen 
presentation 
The inhibitory effect of Abp1 deficiency on BCR internalization and transport to late 
endosomes suggests a reduced efficiency of antigen processing and presentation in Abp1-
/- splenic B cells.  To test this hypothesis, we determined the antigen processing and 
presentation efficiency of mouse splenic B cells using an Eα peptide (a.a. 52-68)-red 
fluorescent protein (EαRFP) chimera as the antigen.  To follow BCR-mediated antigen 
processing and presentation, we targeted EαRFP to the BCR using an antibody complex.  
The specific internalization and delivery of EαRFP by the BCR to late endosomes was 
confirmed by flow cytometry and immunofluorescence microscopy respectively (data not 
shown).  Eα peptide-loaded MHC class II I-Ab complexes (Eα-I-Ab) were detected using 
Y-Ae mAb (150, 151), indicating levels of antigen presentation.  Splenic B cells were 
incubated with different concentrations of EαRFP alone for pinocytosis-mediated antigen 
processing or EαRFP plus the antibody complex for BCR-mediated antigen processing at 
37oC for 10 min to allow antigen internalization, and then washed and incubated at 37oC 
for 14 h.  The surface Eα-I-Ab staining levels were quantified by flow cytometry.  The 
surface Eα-I-Ab level of wt splenic B cells incubated with the antigen-antibody complex 
was significantly higher than those incubated with EαRFP alone (Fig. 2.3A-B), indicating 
a higher efficiency of BCR-mediated antigen processing and presentation than that of 
non-specific mechanisms.  In addition, the level of surface Eα-I-Ab on wt splenic B cells 
that were incubated with the antigen-antibody complex increased with the concentration 
of the complex (Fig. 2.3B).  In comparison with wt splenic B cells, the surface Eα-I-Ab 
level in Abp1-/- B cells was significantly lower and did not increase with the 
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concentration of the antigen-antibody complex (Fig. 2.3A-B).   BCR crosslinking 
increased the surface levels of MHC class II in both wt and Abp1-/- splenic B cells, and 
Abp1-/- B cells showed MHC class II expression levels similar to wt B cells before and 
after BCR crosslinking by the antigen-antibody complex (Fig. 2.3C).  These results 
indicate that the decrease in surface Eα-I-Ab levels was not the result of decreased I-Ab 
expression.  These data indicate that Abp1-deficiency decreases the efficiency of BCR-
mediated antigen processing and presentation. 
 
2.4.3 BCR activation induces recruitment of Abp1 to the plasma membrane and 
the internalizing BCR 
To examine the relationship of Abp1 with BCR signaling pathway, we analyzed the 
cellular redistribution of Abp1 in response to BCR activation in both A20 and splenic B 
cells using immunofluorescence microscopy. B cells were activated via incubation with 
crosslinking antibody for 2 and 10 min at 37°C, fixed, permeabilized, and labeled with an 
antibody specific for Abp1.  In the absence of BCR crosslinking, Abp1 was primarily 
located in the cytoplasm (Fig. 2.4Aa-b, and 2.4Ca).  BCR crosslinking for 2 min led to a 
redistribution of Abp1 to the cell surface (Fig. 2.4Af-g, and 2.4Ce).  Nearly 55% of the 
A20 B cells showed this redistribution after 2-min of activation, compared to only 10% 
of the unstimulated cells (Fig. 2.4B).  By 10 min, Abp1 began returning to the cytoplasm 
(Fig. 2.4Ak-l, and 2.4Ci). Such redistribution from the cytoplasm to plasma membrane in 
response to BCR activation was observed with both transfected myc-Abp1 and 
endogenous Abp1 in A20 and splenic B cells (Fig. 2.4A-C), showing that transfected 
myc-Abp1 behaved in a similar manner to the endogenous Abp1. 
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FIGURE 2.3. B cells from Abp1 knockout mice are defective in Antigen processing 
and presentation.   
(A) Splenic B cells from wt (filled) and Abp1-/- (dotted) mice were incubated at 37oC for 10 
min with EαRFP (1 μg/ml) alone (gray line) or with the antibody complex that targets 
EαRFP to the BCR.  Cells were washed and incubated at 37oC for 14 h.  Eα peptide-loaded 
MHC class II I-Ab complexes on the cell surface were detected using anti-Y-Ae mAb and 
quantified using flow cytometry.  (B) Splenic B cells from wt (open squares) and Abp1-/- 
(closed squares) mice were incubated with different concentrations of EαRFP alone or 
EαRFP-antibody complexes as described in A.  Splenic B cells from wt mice were incubated 
with different concentrations of EαRFP alone (triangles).  Cells were stained and analyzed as 
described above.  Shown are the averages (±S.D.) of mean fluorescence intensity of Y-Ae 
staining from three independent experiments.  **, p<0.01.  (C) The expression levels of 
MHC class II I-Ab of splenic B cells from wt (solid line) and Abp1-/- (dotted lines) mice 
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To examine the cellular distribution of Abp1 relative to the antigen bound BCR, the 
surface BCR in both A20 and splenic B cells were labeled and cross-linked at 4oC and the 
cells were warmed up to 37°C for 2 and 10 min.  After fixation and permeabilization, 
myc-Abp1 and endogenous Abp1 was labeled with anti-myc mAb and anti-Abp1 
antibody, respectively.  Before the cells were warmed to 37oC, Abp1 was primarily 
localized in the cytoplasm, and there was little colocalization of the cytoplasmic Abp1 
with the surface BCR observed (Fig. 2.4Ab-e and 2.4Ca-d).  After 2-min incubation at 
37oC, we observed a dramatic increase in the colocalization of Abp1 with the BCR at the 
cell surface (Fig. 2.4Ag-j mad 2.4Ce-h), suggesting that Abp1 was recruited to the 
surface BCR in response to the stimulation.  By 10 min, when some of the BCR had been 
internalized and moved to late endosomes, Abp1 began moving back to the cytoplasm, 
however, some remained colocalized with the intracellular BCR (Fig. 2.4Al-o and 2.4Ci-
l).  The correlation analysis of splenic B cells showed an increase in the colocalization of 
Abp1 with the BCR at 2 min after BCR crosslinking, and this colocalization declined at 
later time points (Fig. 2.4D).  These results showed that BCR stimulation induced the 
recruitment of Abp1 to the surface and internalizing BCR. 
 52
 
FIGURE 2.4. BCR activation induces the redistribution of Abp1 to the plasma 
membrane.  
 (A and C) A20 (A) and splenic B cells (C) were treated (+XL) or untreated (-XL) with 
either goat anti-mouse IgG (Aa, Af, and Ak) or AF488 goat-anti-mouse IgG (Ab-e, Ag-j, 
Al-o and C) at 4oC and chased at 37oC for indicated times.  After fixation and 
permeabilization, cells were labeled with anti-Abp1 antibody for the endogenously 
expressed Abp1 (Aa, Af, Ak, and C) or anti-myc antibody for myc-Abp1 (Ab-e, g-j, and l-
o).  Cells were analyzed using a confocal fluorescence microscope.  Shown are 
representative images from three independent experiments.  Bar, 5 μm.  (B) The 
redistribution of endogenous Abp1 and myc-Abp1 from the cytoplasm to the cell surface 
after BCR crosslinking for 2 min was quantified by visual inspection.  Over 100 cells 
from five randomly selected fields of each experiment were analyzed, and the numbers of 
cells showing Abp1 concentrated on the cell surface were plotted as percentages of the 
total number of cells inspected.  Shown are averages (±S.D.) from three independent 
experiments. * p<0.05, ** p<0.01. (D) The correlation coefficients of endogenous Abp1 
with the BCR in splenic B cells before and after BCR crosslinking was determined using 
the LSM510 software. Shown are the data generated from >100 cells of two independent 
experiments. Black bars indicate the mean.  ** p<0.01, paired two tailed student t test of 














c                            l               m           n      o
g              h             i              j





































BCR Merge  Colocalized 
Splenic B cells
a                b               c                d
e                f                g               h


























-XL    2     10     30 
Time (min)
 
2.4.4 BCR-induced redistribution of Abp1 depends on BCR-induced tyrosine 
phosphorylation of Abp1 
Abp1 has been reported to undergo tyrosine phosphorylation at Y337 and Y347 in 
response to BCR stimulation (114).  To test whether BCR-induced tyrosine 
phosphorylation of Abp1 is related to its cellular distribution, we followed the time 
course of the tyrosine phosphorylation of endogenous Abp1 and transfected myc-Abp1.  
Untransfected A20 B cells and A20 B cells that were transfected with full length myc-
Abp1 were activated for indicated times by crosslinking the BCR.  Cells were lysed, and 
the cell lysates were subjected to immunoprecipitation using anti-Abp1 antibody for 
endogenous Abp1 or anti-myc mAb for transfected myc-Abp1.  The immunoprecipitates 
were analyzed by SDS-PAGE and Western blot, probing for phospho-tyrosine.  As 
shown in Fig. 2.5A, crosslinking of the BCR increased the tyrosine phosphorylation of 
endogenous Abp1 as early as 2 min and this increase appeared to be sustained at least for 
30 min (Fig. 2.5A, top panels).  Similarly, BCR crosslinking induced the tyrosine 
phosphorylation of myc-Abp1.  This phosphorylation peaked at 2 min, but rapidly 
decreased to undetectable levels by 10 min (Fig. 2.5A, bottom panels).  These results 
show that BCR crosslinking increases tyrosine phosphorylation of Abp1 at a time 
corresponding to BCR-induced redistribution of Abp1.  
 
To test whether BCR-induced tyrosine phosphorylation of Abp1 is important for its 
cellular redistribution, we determined the effect of mutations of Abp1 tyrosines 337 and 
347 into phenylalanines (Abp1 Y337F/Y347F) on the cellular redistribution of Abp1.  
The DNA construct of myc-Abp1 Y337FY347F was introduced into A20 B cells by 
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FIGURE 2.5. BCR-induced cellular redistribution of Abp1 is dependent on BCR-
induced tyrosine phosphorylation of Abp1.   
(A) Untransfected A20 B cells (top) and A20 B cells transfected with myc-Abp1 (bottom) 
were treated (+XL) or untreated (-XL) with goat-anti-mouse IgG for varying lengths of 
time to activate the BCR.  Then cells were lysed, and endogenous Abp1 and myc-Abp1 
were purified from cell lysates by immunoprecipitation using anti-Abp1 and anti-myc 
antibodies, respectively.  The immunoprecipitates were analyzed by SDS-PAGE and 
Western blot, probing with anti-phosphotyrosine mAb (4G10).  The blots were stripped 
and reblotted with anti-Abp1 or anti-myc antibody.  Shown are representative blots of 
three independent experiments.  (B) A20 cells transiently transfected with wt myc-Abp1 
(Ba-Bb) and myc-Abp1 Y337F/Y347F (Bc-Bd) were treated (+XL) and untreated (-XL) 
with goat anti-mouse IgG for 2 min, and then fixed, permeabilized, and labeled with Cy3-
anti-myc mAb for myc-Abp1.  Cells were analyzed using a confocal fluorescence 
microscopy.  Shown are representative images of three independent experiments.  Bar, 10 
μm.  (C) Cells in images were quantified as described in Fig. 2.4B. Over 100 cells from 
three independent experiments were analyzed.  Shown are the averages (±S.E.) from 
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transfection and the cellular redistribution of expressed protein was analyzed by 
immunofluorescence microscopy in comparison to wt myc-Abp1 (Fig. 2.5Ba-Bd).  The 
percentage of wt myc-Abp1-expressing cells showing cell surface redistribution of Abp1 
increased from 20% to 80% after BCR crosslinking for 2 min (Fig. 2.5Ba-Bb and 2.5C).  
In contrast, there was no significant increase in the percentage of Abp1 Y337F/Y347F-
expressing cells showing the redistribution (Fig. 2.5Bc-Bd and 2.5C).  This indicates that 
the Abp1 redistribution depends on BCR-induced tyrosine phosphorylation of Abp1.  
 
2.4.5 BCR-induced Abp1 redistribution depends on the actin cytoskeleton 
BCR activation induces reorganization of the actin cytoskeleton (35, 87).  The presence 
of two ABDs in Abp1 implies that its cellular redistribution may rely on BCR-induced 
actin cytoskeleton reorganization.  To test this hypothesis, we analyzed the cellular 
distribution of Abp1 relative to F-actin and tested the effect of a G-actin sequestering 
agent latrunculin B on BCR-induced redistribution of Abp1.  In A20 B cells, myc-Abp1 
was colocalized with F-actin extensively with and without BCR activation (Fig. 2.6A).  
Both F-actin and endogenous Abp1 were located at the cell periphery and cytoplasm in 
unstimulated cells (Fig. 2.6Ba) and rapidly moved to the plasma membrane upon BCR 
activation (Fig. 2.6Bc).  In latrunculin-treated cells, Abp1 was primarily located in the 
cytoplasm with (Fig. 2.6Bd) or without BCR activation (Fig. 2.6Bb).  Latrunculin B 
treatment significantly decreased the number of cells showing BCR-induced 
redistribution of Abp1 (Fig. 2.6B-C).  These data indicate that BCR-induced Abp1 
redistribution is dependent on the actin cytoskeleton. 
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FIGURE 2.6.  BCR-induced Abp1 redistribution depends on the actin cytoskeleton.  
(A) A20 cells transiently transected with myc-Abp1 were incubated with (+XL) or 
without (-XL) goat anti-mouse IgG for 1 min.  After fixation and permeabilization, cells 
were labeled with AF488-phalloidin for F-actin and Cy3-anti-myc mAb for myc-Abp1.  
(B) A20 cells were pretreated with or without latrunculin (Lat) and activated in the 
presence or absence of Lat for 1 min.  Cells were labeled with anti-Abp1 antibody and 
AF488-conjugated secondary antibody and analyzed using a confocal fluorescence 
microscopy.  Shown are representative images of three independent experiments.  Bar, 10 
μM.  (C) Cells in images quantified as described in Fig. 2.4B, and shown are averages 
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2.4.6 The interaction of Abp1 with dynamin 2 
The interaction of dynamin and Abp1 through their PRD and SH3 domains has been 
shown to be important for Tf internalization (70).  To examine the relationship between 
Abp1 and dynamin 2 in B cells, we followed the interaction of these two proteins by 
immunofluorescence microscopy, co-immunoprecipitation, and co-precipitation.  
Immunofluorescence microscopy studies showed that similar to Abp1, dynamin 2 was 
primarily distributed in the cytoplasm in the absence of stimulation.  In response to BCR 
crosslinking, dynamin 2 was recruited from the cytoplasm to plasma membrane where it 
colocalized with Abp1 (Fig. 2.7A).  The co-recruitment of dynamin 2 with Abp1 upon 
BCR activation suggests a potential interaction between Abp1 and dynamin 2.  To further 
test whether the interaction between the two proteins depends on their SH3 and PRDs, we 
co-transfected A20 B cells with myc-Abp1 and GFP-dynamin 2 (GFP-Dyn, Fig. 2.7Ba-l) 
or GFP-dynamin 2 with its PRD deleted (GFP-∆PRD, Fig. 2.7Bm-x) and followed the 
cellular distribution of these proteins by immunofluorescence microscopy.  Similar to 
endogenous dynamin 2, GFP-Dyn showed a cytoplasmic distribution in the absence of 
stimulation (Fig. 2.7Bc) and was recruited to the cell surface where it colocalized with 
myc-Abp1 and the BCR after crosslinking of the BCR for 5 min (Fig. 2.7Be-h).  By 30 
min, both proteins accumulated in the perinuclear region with the BCR (Fig. 2.7Bi-l).  In 
cells co-expressing myc-Abp1 and GFP-∆PRD, both proteins appeared to be in the 
cytoplasm without BCR activation (Fig. 2.7Bm-p).  Upon BCR crosslinking, both GFP-
∆PRD and Abp1 showed punctuate staining patterns (Fig. 2.7Br-t and 2.7Bv-x).  In 
contrast to what was observed in cells co-expressing GFP-Dyn and myc-Abp1, GFP-
∆PRD and Abp1 were neither recruited to the cell surface, nor colocalized with each 
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other (Fig. 2.7Bq-x).  The correlation analysis further showed that the colocalization 
coefficients between GFP-Dyn and myc-Abp1 were increased in response to BCR 
activation (Fig. 2.7C).  In contrast, there was no significant increase in the colocalization 
coefficients between GFP-∆PRD and myc-Abp1 following BCR activation (Fig. 2.7C). 
These results suggest that dynamin 2 interacts with Abp1 through its PRD. 
 
We further examined the interaction between dynamin 2 and Abp1 using co-
immunoprecipitation and GST-fusion protein co-precipitation.  The cell lysates from 
unstimulated and stimulated A20 B cells were subjected to immunoprecipitation using a 
polyclonal antibody specific for Abp1.  The presence of dynamin 2 in the Abp1 
immunoprecipitates was detected by a dynamin 2-specific antibody.  As shown in Fig. 
2.7D, dynamin 2 was detected in the Abp1 immunoprecipitates in the presence or 
absence of BCR activation, and dynamin 2 was absent only when anti-Abp1 antibody 
was omitted.  This result indicates a constitutive interaction between dynamin 2 and 
Abp1.  To further confirm that this interaction is mediated through the PRD of dynamin 2 
and the SH3 domain of Abp1, we used a GST fusion protein of dynamin 2 PRD (GST-
Dyn-PRD) to precipitate Abp1 from the lysates of cells expressing full length myc-Abp1 
and myc-Abp1 ABDs.  Similar to the co-immunoprecipitation of endogenous dynamin 2 
with Abp1, GST-Dyn-PRD co-precipitated similar amounts of myc-Abp1 from the lysate 
of A20 cells that were treated or untreated with BCR crosslinking antibodies (Fig. 2.7E), 
confirming the constitutive interaction of dynamin 2 with Abp1.  In contrast, GST-
dynamin-PRD failed to precipitate myc-Abp1 ABDs (Fig. 2.7E), indicating that the PRD 
and SH3 domains of dynamin and Abp1 are essential for their interaction.  These results  
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FIGURE 2.7.  Interaction of Abp1 with Dynamin 2.   
(A) A20 cells were incubated with (+XL) and without (-XL) goat anti-mouse IgG for 
indicated times, and then fixed, permeabilized, and labeled with anti-Abp1 and anti-
dynamin 2 antibodies and corresponding secondary antibodies. The cells were analyzed 
using a confocal fluorescence microscope.  Shown are representative images from three 
independent experiments.  Bar, 10 μm.  (B) A20 cells were co-transected with myc-Abp1 
and GFP-dynamin 2 (GFP-Dyn) (a-l) or GFP-dynamin 2 with PRD deletion (GFP-∆PRD) 
(m-x). The cells were incubated with (+XL) (e-l, q-x) and without (-XL) (a-d, m-p) goat 
anti-mouse IgG for indicated times, and then fixed, permeabilized, and labeled with Cy3-
anti-myc antibody to label myc-Abp1. The cells were analyzed by confocal fluorescence 
microscopy. Shown are representative images from three independent experiments. Bar, 
10 μm. (C) Shown are the correlation coefficients between myc-Abp1 and GFP-Dyn or 
GFP-ΔPRD in the cell surface area of >30 cells from three independent experiments. 
Black bars represent the mean correlation coefficient.  * p<0.05, paired two tailed student 
t test of mean correlation coefficient from three independent experiments. (D) A20 cells 
were treated or untreated (-XL) with BCR crosslinking antibody for indicated times.  The 
cells were lysed, and the cell lysates were subjected to immunoprecipitation using goat 
anti-Abp1 antibody.  The cell lysates and immunoprecipitates were analyzed using SDS-
PAGE and Western blot, probing for dynamin 2. The blots were stripped and reblotted 
with anti-Abp1 antibody as loading controls.  Shown are representative blots from three 
independent experiments.  (E) A20 cells transiently transfected with myc-Abp1 or myc-
Abp1 ADF-H were activated by crosslinking the BCR with goat anti-mouse IgG for 
indicated times and then lysed.  The cell lysates were incubated with GST-fusion of 
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dynamin PRD bound beads.  The cell lysates and precipitates were subjected to SDS-
PAGE and Western blot, probing for myc-Abp1.  The blots were stripped and reblotted 
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 further confirm that Abp1 and dynamin 2 may constitutively interact with each other 
through their SH3 and PRDs.  
 
2.5 Discussion 
This study revealed a critical role for Abp1 in BCR-mediated antigen processing and 
presentation.  Abp1 gene knockout and overexpression of the Abp1 SH3 domain reduced 
the rates of BCR-mediated antigen uptake, consequently reducing the rate of antigen 
transport to the antigen processing compartment and the efficiency of antigen processing 
and presentation.  B cells process and present antigens to acquire T cell help, which is 
essential for the induction of isotype switching, somatic hypermutation, and affinity 
maturation in B cells.  The BCR increases B cell antigen processing and presentation 
efficiency by binding to antigens with high specificity and affinity and by initiating rapid 
internalization and transport of antigens to antigen processing compartments.  This allows 
B cells to present specific antigens even when antigen concentrations are extremely low.  
A previous study showed defective antibody responses to T cell-dependent antigens and 
reduced T cell receptor-mediated signaling and T cell activation in Abp1-/- mice (123).  
Here, we discovered defects in antigen processing and presentation of Abp1-/- B cells.  
Lowering the efficiency of B cells to process and present antigens to T cells would 
decrease the sensitivity of T cell-dependent B cell activation, contributing to defective T 
cell-dependent antibody responses in Abp1-/- mice.  Abp1 contains two independent F 
actin-binding domains in the N-terminus, and a SH3 domain and a PRD or flexible 
domain in its C-terminus (114, 115, 118).  Its multiple protein-protein interacting 
domains enable Abp1 to interconnect different cellular apparatuses.  Previous studies 
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implicate Abp1 as an actin adaptor protein connecting the actin cytoskeleton to 
endocytosis machinery.  The null mutation of the yeast homologue of Abp1, Abp1p, 
resulted in defects similar to those seen in Rvs167/amphiphysin mutation, including 
sporulation and reduced viability under certain suboptimal growth conditions.  Double 
mutations in ABP1 and RVS167/amphiphysin genes or one of the genes encoding other 
cytoskeletal components were genetic lethal (152).  In mammalian cells, Abp1 has been 
shown to be essential for Tf receptor internalization (70, 148) and synaptic vesicle 
recycling (147).  Here, we showed that Abp1 was required for efficient BCR-mediated 
antigen internalization, further demonstrating an essential role for Abp1 in endocytosis.  
Previous studies have shown that Abp1 interacts directly with proteins of the endocytic 
machinery, including rvs167/amphiphysin in yeast (152) and dynamin in mammalian 
cells (70).  Both amphiphysin and dynamin are important for the membrane fission step 
of endocytosis (91, 153).  Furthermore, Abp1p was recruited to the endocytosis sites 
along with Arp2/3 and actin in yeast (146), suggesting a role for Abp1 in endocytic 
vesicle formation from the plasma membrane.  However, a recent study using Abp1-/- 
mice placed Abp1 function downstream of vesicle fission in synaptic vesicle recycling in 
hippocampal neurons (147).  Our previous studies showed that the dynamic properties of 
the actin cytoskeleton were required for BCR internalization at the fission step of 
clathrin-coated vesicle formation (35).  Here we found that Abp1-deficiency and actin 
depolymerization inhibited BCR internalization to a similar extent.  Furthermore, Abp1, 
F-actin, and dynamin 2 were recruited to the BCR at the plasma membrane at the same 
time and appear to interact with each other.  These findings further support a role for 




Unlike the constitutive internalization of Tf receptor, BCR internalization is triggered by 
antigen binding and is dependent on BCR-mediated signaling (40, 127-129).  Previously, 
our lab showed that BCR activation induced the recruitment of clathrin to the BCR and 
phosphorylation of clathrin within lipid rafts, both of which were required for BCR 
internalization (140).  In this study, we found that BCR activation induced the 
recruitment of Abp1 to the plasma membrane and to the internalizing BCR, suggesting 
that BCR signaling regulates the function of Abp1.  Indeed, our data revealed that BCR 
activation induced tyrosine phosphorylation of Abp1 and that this phosphorylation was 
required for the recruitment of Abp1 to the cell surface and BCR.  Abp1 colocalized with 
cortical F-actin, and BCR-induced recruitment of Abp1 to the cell surface depended on 
the actin cytoskeleton.  These data indicate that BCR signaling can regulate the 
subcellular location of Abp1 through the tyrosine phosphorylation of Abp1 and the 
reorganization of the actin cytoskeleton.  This is in line with a previous study showing the 
translocation of Abp1p from the perinuclear region to the leading edge of cells in a 
pattern that overlaps with Arp2/3 complex localization in response to activation of the 
GTPase Rac (115).  The finding of a synchronized cellular reorganization of the actin 
cytoskeleton, Abp1 and dynamin 2 in response to BCR stimulation suggests that BCR 
signaling regulates the interaction of Abp1 with the actin cytoskeleton and dynamin 2.  
The interaction of Abp1 with dynamin during clathrin-mediated endocytosis has been 
previously reported (70).  Here, we demonstrate this interaction in B cells by co-
immunoprecipitation and GST fusion protein co-precipitation.  While the interaction 
between Abp1 and dynamin 2 appeared to be constitutive, our observation of co-
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recruitment of Abp1 and dynamin 2 to the plasma membrane following BCR activation 
indicates that BCR signaling regulates the subcellular location where Abp1 and dynamin 
2 interact.  
 
Another possible mechanism through which Abp1 functions in endocytosis is by 
regulating the dynamics of the actin cytoskeleton.  In yeast, Abp1p recruits Arp2/3 
complexes to the sites of actin filaments and is required for Arp2/3 complex activation in 
vitro (116).  Over expression of Abp1p in yeast causes severe defects in cellular actin 
organization (144).  Pinyol et al. (145) recently showed that Abp1 directly interacted with 
N-WASP, an activator of Arp 2/3 complex, and activated N-WASP in cooperation with 
Cdc42, suggesting that Abp1 may regulate the actin cytoskeleton indirectly through N-
WASP. However, obvious defects in the actin cytoskeleton have not been observed in 
Abp1-/- B cells and B cells over expressing Abp1 and its dominant negative mutants (data 
not shown).   
 
Abp1 has been shown to serve as a signaling regulator in T cells.  Abp1 is recruited to the 
immunological synapse formed between T cells and antigen-presenting cells (122) and 
regulates the distal signaling of the TCR, including the activation of HPK1, the MAP 
kinase JNK, and the transcription factor NFAT (118, 119, 123).  It is possible that Abp1 
plays a similar role in regulation of BCR signaling events, which may provide feedback 
signals from the actin cytoskeleton and endocytic machinery to the BCR-mediated 




This study demonstrates the role of Abp1 in coupling BCR signaling and antigen 
processing/presentation functions by interacting with BCR signaling, endocytic, and actin 
cytoskeletal apparatuses.  BCR activation induced Abp1 tyrosine phosphorylation and 
actin cytoskeleton reorganization, both of which are required for the recruitment of Abp1 
to BCR internalization sites.  Upon being recruited to the plasma membrane, the 
interaction of Abp1 with the actin cytoskeleton and endocytic proteins, such as dynamin 
2, drives BCR internalization.  Future studies will further examine the molecular 
mechanisms for interactions of Abp1 with BCR signaling, endocytic, and actin 
cytoskeletal apparatuses and regulatory mechanisms for these interactions. 
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The binding of multi-valent antigens to the B cell antigen receptor (BCR) initiates signaling 
cascades, actin cytoskeleton reorganization and rapid internalization of the BCR-antigen 
complex for antigen processing.  BCR internalization has been shown to primarily take place 
via clathrin-mediated endocytosis.  Previous studies have demonstrated links among the actin 
cytoskeleton, BCR-mediated signaling and antigen uptake, however the molecular nature of 
such links has not been fully elucidated.  Here, I studied the role of dynamin 2, a GTPase 
required for the fission of clathrin-coated vesicles from the plasma membrane, in coupling 
BCR signaling, actin cytoskeleton, and BCR internalization.  It was found that BCR 
signaling induced the recruitment of dynamin 2 to the plasma membrane where it colocalized 
with the BCR and the actin cytoskeleton during BCR internalization.  A PRD deletion 
mutation abrogated this recruitment.  The recruitment of dynamin 2 to the plasma membrane 
was sensitive to PP2, a Src kinase inhibitor, but not latrunculin B which depolymerizes F-
actin.  While overexpression of dynamin 2 with a deletion of PRD did not significantly alter 
the organization of the actin cytoskeleton, it blocked BCR internalization and reduced the 
colocalization of the actin cytoskeleton with the BCR and dynamin 2.  These results indicate 
that BCR-triggered signaling regulates the subcellular location of dynamin 2, and dynamin 2 





In naïve B cells, prior to crosslinking with antigen, the BCR is constitutively internalized 
via clathrin mediated endocytosis (CME) and recycles through the early endosome back 
to the cell surface (130). When the BCR encounters an antigen, oligomerization of the 
BCR by antigens leads to tyrosine phosphorylation of the Ig α/Ig β heterodimer, the 
signaling component of the BCR complex that is non-covalently bound to membrane 
immunoglobulin (6). The BCR then initiates signaling cascades that lead to the 
transcription and translation of genes required for B cell activation.  In addition, BCR-
triggered signaling facilitates the internalization of the BCR-antigen complex and the 
targeting of the complex to the antigen-processing compartment also called the MIIC 
compartment (154).  In the MIIC compartment, antigens are fragmented and loaded unto 
the MHC class II complex and eventually presented on the surface of B cells to engage 
cognate T cells (14).   
 
Previous studies from our lab and others have demonstrated that crosslinking of the BCR 
increases the antigen processing and presentation efficiency of B cells by increasing the 
kinetics and specificity of antigen uptake and transport to the MIIC.  This allows B cells 
to effectively present an antigen even at very low concentrations of antigen and during a 
very short antigen exposure (127, 154).  BCR signaling and antigen processing have been 
shown to be interrelated.  Tyrosine kinase inhibitors that block BCR signaling were 
shown to inhibit accelerated antigen transport and also reduce the antigen-presenting 
efficiency of B cells (40, 129).  We showed previously that crosslinking the BCR induced 
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the recruitment of clathrin to the cell surface, where it colocalized with BCR-containing 
vesicles, and the tyrosine phosphorylation of clathrin in lipid rafts (33).   
 
The actin cytoskeleton has long been suspected of having a role in the generation of 
CME. It has been observed that F-actin was actively recruited to newly formed clathrin-
coated vesicles just at the point of detachment from the plasma membrane, which raises 
the possibility that the actin cytoskeleton may have a role in the membrane fission step of 
CME (55, 155, 156). However, the use of various actin-disrupting agents has given 
conflicting results. In some systems, disrupting the actin cytoskeleton actually enhanced 
endocytosis (157).  This is probably due to a barrier activity of cortical actin at the 
plasma membrane which inhibits the inward movement of clathrin-coated vesicles.  
Research by our lab and others is beginning to reveal a role for the actin cytoskeleton in 
BCR-mediated activation of B cells.  Previous studies showed that antigen binding 
induced the translocation of the BCR and tyrosine kinases Lyn and Syk to the detergent-
insoluble cytoskeletal fractions (133-135), reorganization of the actin cytoskeleton (90, 
136-139), and transient increases in F-actin levels in B cells (35, 87).  We have 
previously shown that the dynamic property of the actin cytoskeleton was required for 
signal-stimulated BCR internalization.  BCR endocytosis is blocked at the pinching-off 
step during clathrin-coated vesicle formation in the absence of a functional actin 
cytoskeleton. Allam et al. (35) has revealed a role for the B-lymphocyte associated 
adaptor protein (Bam 32) in BCR-meditated actin reorganization. Bam32 was recruited to 
the BCR and F-actin rich areas of cells in response to BCR activation and regulated 
BCR-triggered actin polymerization through interactions with the Rho-family GTPase 
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Rac1 (85, 86, 88). Although these recent studies have provided evidence for the 
involvement of the actin cytoskeleton in BCR endocytosis, the molecular link between 
the actin cytoskeleton and BCR internalization pathway remains to be defined.  Previous 
studies have revealed a number of proteins that might play a role in connecting the actin 
cytoskeleton to CME. Some of the proteins that are capable of binding both F-actin and 
proteins involved in CME include Huntington-interacting protein-1 (71), cortactin, (69, 
108, 156), actin binding protein 1 (Abp1) (70, 158), and Myosin VI (159).  
 
Dynamin is a GTPase that is involved in pinching off vesicles in a number of membrane 
processes (91).  Dynamin is composed of multiple domains, including a PH domain that 
binds to PI(4,5)P on the plasma membrane, a GTPase domain that provides a signal for 
membrane fission, and a PRD that binds to an ever expanding list of SH3 domain-
containing proteins (63). As a GTPase, dynamin provides mechanical force that constricts 
the neck of nascent endocytic vesicles (160). Recently dynamin has also been shown to 
be involved in connecting the actin cytoskeleton to the clathrin-mediated endocytosis 
pathway (63, 161). Although there is no evidence for a direct interaction between 
dynamin and F-actin, dynamin has been shown to interact with a number of proteins that 
interact with the actin cytoskeleton (63).  In T cells, dynamin has been shown to be 
important for actin reorganization at the immunological synapse that is formed between a 
T cell and an antigen-presenting cell. Dynamin knockdown inhibited T cell antigen 
receptor-triggered signal transduction, probably due to the failure of formation of the 
immunological synapse (100).  Unsworth et al. showed that dynamin is required for the 
formation of actin-based pedestals in enteropathogenic E.coli-infected epithelial cells 
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(112), implying a role in regulating the actin cytoskeleton, in addition to linking the actin 
cytoskeleton to the endocytic machinery. 
 
Here I studied the role of dynamin in BCR-mediated antigen uptake and showed that BCR 
internalization requires dynamin. In response to BCR activation, dynamin 2 was recruited to 
the plasma membrane, the internalizing BCR, and the actin cytoskeleton, and this recruitment 
was dependent on the PRD of dynamin and BCR-triggered signaling, but not the actin 
cytoskeleton.  
 
3.3 Materials and Methods 
3.3.1 DNA constructs and transfection.    
B cell lymphoma A20 IIA1.6 cells (H-2d, IgG2a+, FcγRIIB-) were cultured at 37oC in DMEM 
supplemented with 10% FBS.  The DNA constructs for GFP fusion protein of dynamin 2aa 
(GFP-Dyn) and dynamin 2aa mutant with its PRD deleted (GFP-Dyn ∆PRD) were kindly 
provided by Dr. Mark McNiven, (Mayo Clinic, Rochester), and the DNA construct of GFP 
fusion protein of actin (GFP-actin) was obtained from Clonetech. DNA constructs were 





3.3.2 Analysis of the movement of the BCR from the cell surface to late 
endosomes.  
A20 B cells, untransfected or transfected with either GFP-Dyn or GFP-Dyn ∆PRD, were 
incubated with Alexa Fluor (AF) 546-conjugated F(ab’)2-goat anti-mouse IgG (Invitrogen,  
Carlsbad, CA) for 20 min at 4oC to label the surface BCR.  Cells were washed and then 
adhered to poly-lysine-coated slides (Sigma-Aldrich) for 20 min at 4oC and then chased at 
37oC for varying lengths of time to allow for the internalization of the BCR.  At each time 
point, cells were fixed with 4% paraformaldehyde, permeabilized with 0.05% saponin in 
DMEM, 10%FBS, 10mM Hepes and 10mM glycine, and incubated with a mAb specific for 
lysosome-associated membrane protein 1 (LAMP-1) (ID4B, ATCC, Manassas, VA) and an 
AF633-conjugated secondary antibody.  Cells were mounted with gel mount (Biomeda, 
Foster City, CA) and analyzed using a laser-scanning confocal microscope (LSM 510; Zeiss, 
Oberkochen, Germany).  For quantitative analysis of images, the cellular distribution of the 
BCR was divided into two different categories:  the BCR mainly distributed on the cell 
surface without colocalization with LAMP-1 or extensively colocalized with LAMP-1 at the 
perinuclear region of cells.  Cells were categorized by visual inspection to determine the 
localization pattern of the BCR.  Over 100 cells from three independent experiments were 
analyzed for each time point.  
 
3.3.3 Analysis of BCR internalization.   
A20 B cells, untransfected or transfected with either GFP-Dyn or GFP-Dyn ∆PRD, were 
incubated with biotinylated goat anti-mouse IgG (20 µg/ml; Jackson ImmunoResearch) for 
30 min at 4oC to label the surface BCR.  After washing off unbound antibodies, cells were 
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chased at 37oC for varying lengths of time.  The chase was terminated by adding ice-cold 
DMEM containing 6 mg/ml BSA (DMEM-BSA).  The biotinylated antibodies remaining on 
the cell surface after the chase were stained with PE-streptavidin (5 µg/ml; Qiagen, Valencia, 
CA) at 4oC.  The cells were then fixed with 2% paraformaldehyde and analyzed using a flow 
cytometer (FACSCalibur, BD Bioscience, San Jose, CA).  GFP-expressing cells were gated 
for analysis. The data was plotted as a percentage of the mean fluorescence intensity of cell-
surface PE-streptavidin at time 0. 
 
3.3.4 Analysis of cellular distributions of BCR, F-actin, and dynamin 2.  
Untransfected A20 B cells or A20 cells transfected with either GFP-Dyn or GFP-Dyn ∆PRD 
were incubated with Cy3 (Jackson ImmunoResearch) or AF 633 (Invitrogen)-conjugated Fab 
fragment of goat anti-mouse IgG (5 µg/ml) for 10 min at 4oC to label the surface BCR, 
followed by rabbit anti-mouse IgG (20 µg/ml, Jackson ImmunoResearch) for indicated times 
at 37oC to crosslink the BCR.  Cells were fixed with 4% paraformaldehyde, permeabilized 
and stained with anti-dynamin antibody (BD biosciences) followed by AF488-anti-mouse 
IgG1 as a secondary antibody for endogenous dynamin 2. AF 555-phalloidin (Invitrogen) was 
used to stain for F-actin in GFP-Dyn transfected cells.  Cells were analyzed using a confocal 
fluorescence microscope.   
 
3.3.5 Live cell imaging.  
GFP-actin, GFP-Dyn, or GFP-Dyn ∆PRD were introduced into A20 B cells by 
electroporation using Nucleofection kit (Amaxa). 24 hours after transfection, cells were 
 80
 
placed into chambered polylysine (10 µM)-coated cover glasses (Nalge Nunc Int. Rochester, 
NY) and incubated at 37°C, 5% CO2 for 30 min. Cells were then incubated with Cy3-Fab-
goat anti mouse IgG (5 μg/ml; Jackson ImmunoResearch) at room temperature for 10 min, 
washed with 1%FBS in PBS. Cells were activated by crosslinking the BCR with rabbit-anti-
mouse IgG (20 μg/ml; Jackson ImmunoResearch) and images were acquired every 3 
seconds. Some of the images were acquired using the Zeiss LiveDUO confocal microscope 
while other images were obtained using the Zeiss LSM510.  
 
3.4 Results 
3.4.1 BCR crosslinking induces the recruitment of Dynamin 2 to the plasma 
membrane and to the BCR.   
BCR crosslinking has been shown to increase the phosphorylation of clathrin and induce 
its recruitment to the cell surface where it colocalizes with the BCR (33). Dynamin 2 has 
also been shown to recruit to nascent clathrin-coated vesicles prior to the scission event 
during CME (55). To test whether dynamin 2 is regulated by BCR activation, we 
monitored the cellular distribution of dynamin 2 after BCR crosslinking using 
immunofluorescence microscopy.  The surface BCR of A20 B cells were labeled with 
Cy3-conjugated Fab fragment of goat anti-mouse IgG and cross-linked by rabbit-anti-
mouse IgG for varying lengths of time. After fixation and permeabilization, cells were 
stained for dynamin 2. Prior to BCR crosslinking, dynamin 2 was distributed mainly in 
the cytoplasm (Fig. 3.1Aa-c). Ten minutes after BCR crosslinking, dynamin 2 had 
redistributed from the cytoplasm to the cell periphery where it colocalized with the BCR 
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(Fig. 3.1Ad-f). 30 min after BCR crosslinking we observed that dynamin 2 still remained 
colocalized with the clustered BCR in the perinuclear region of the cell (Fig. 3.1Ag-i). 
Using A20 cells expressing GFP-Dyn or GFP-Dyn ∆PRD mutant, I examined BCR-
induced dynamin 2 redistribution in live cells.  The BCR on transfected cells was labeled 
with Cy3-Fab-anti-mouse IgG and cross-linked with anti-mouse IgG. Cells were imaged 
before and after BCR crosslinking. Similar to what was seen with the endogenous 
dynamin in fixed cells, prior to BCR crosslinking, GFP-Dyn 2 was evenly distributed in 
the cytoplasm (Fig. 3.1Ba), 2 min after BCR crosslinking GFP-Dyn was colocalized with 
the BCR in discrete spots near the plasma membrane (Fig. 3.1Bb).  Surprisingly, while 
the surface labeled BCR underwent characteristic clustering during its internalization, 
dynamin co-clustered with the BCR (Fig. 3.1Bc) and remained with the BCR while it 
moved inwards. This suggests that dynamin 2 remains with nascent endocytic vesicles 
following the internalization of the cargo, which has not been reported before.   By 15 
min GFP-Dyn still remained clustered with the BCR and seemed to accumulate with the 
BCR in the perinuclear region of the cell  (Fig.3.1Bd-Be). In contrast, GFP-Dyn ∆PRD 
mutant failed to redistribute to the cell surface in response to BCR crosslinking (Fig. 
3.1Bf – BJ).  These results show that dynamin 2 is recruited to the cell surface following 
BCR activation where it colocalizes with the BCR during BCR internalization and that 
the PRD of dynamin is required for its recruitment to the cell surface.  
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FIGURE 3.1. Dynamin colocalizes with the BCR following BCR crosslinking.  
(A) A20 B cells were incubated with Cy3-conjugated Fab-goat anti mouse IgG to label the 
BCR and rabbit-anti-mouse IgG to cross-link the BCR for indicated time points. Cells were 
fixed, permeabilized, and labeled with anti-dynamin mAb and a fluorochrome-conjugated 
secondary antibody.  Cells were analyzed using a confocal fluorescence microscope. Shown 
are representative images of three independent experiments.  Bar, 10 μm. (B) A20 B cells 
were transiently transfected with wt GFP-dynamin 2aa (GFP-Dyn) or GFP-dynamin 2aa 
∆PRD mutant (GFP-Dyn-∆PRD).  Twenty-four hours after transfection, the surface BCR 
was labeled with Cy3 Fab-goat anti-mouse IgG on chambered cover glasses and activated by 
crosslinking the BCR with rabbit anti-mouse IgG. Images were acquired every 3 sec with a 
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3.4.2 Dynamin 2 is important for BCR internalization.   
The role of dynamin in membrane fission events has been well established.  The GTPase 
mutation (K44A) and the PH deletion mutation of dynamin 2 have been shown to disrupt 
CME of  transferrin (162), EGFR (163) and the AT1 angiotensin receptor (164, 165). To 
investigate the role of dynamin in BCR internalization, we transiently transfected GFP 
tagged wt and the PRD-deleted mutant of Dynamin 2 into A20 B cells. The BCR of 
transfected B cells were labeled with Cy3-Fab-goat-anti-mouse IgG and crosslinked with 
rabbit-anti-mouse IgG. The internalization of the BCR was monitored using live cell 
imaging. Similar to untransfected cells, in cells that were transiently transfected with wt 
GFP-Dyn, the BCR clearly moved into the cell right after the recruitment of dynamin 2 to 
the cell surface (Fig. 3.1Ba-e).  However, the BCR failed to internalize in cells 
transfected with dynamin ∆PRD mutant (Fig.3.2Aa-d). Next, we further quantified BCR 
internalization in A20 cells transfected with wt GFP-dynamin or its ∆PRD mutant using 
flow cytometry. The surface BCR of A20 B cells were labeled with biotin-conjugated 
anti-mouse IgG at 4°C and chased for 0, 5 and 20 min at 37°C.  Biotin-anti-mouse IgG 
remaining at the cell surface after the chase was detected with PE-streptavidin and 
quantified using flow cytometry.  As shown in Fig. 3.2B, overexpression of GFP-Dyn 
∆PRD significantly decreased the kinetics of BCR internalization while overexpression 
of wt GFP-Dynamin 2 had no significant effect on BCR internalization.  This data 
demonstrates that dynamin 2 is required for BCR internalization, and the PRD of 
dynamin 2 likely plays an important role in BCR internalization although the non specific 




The movement of the BCR from the cell surface to the antigen-processing compartment 
was followed by immunofluorescence microscopy.  The surface BCR was labeled with 
Cy3-Fab-anti-mouse IgG at 4oC and activated with anti-mouse IgG at 37oC for varying 
lengths of time.  After fixation and permeabilization, the antigen-processing compartment 
was marked with anti-LAMP1 mAb.  Cells were analyzed by a confocal fluorescence 
microscope.  Based on the cellular distribution pattern of the BCR and LAMP-1, cells 
were categorized into two groups, BCR colocalizing with LAMP-1 extensively in the 
perinuclear region and BCR remaining on the cell surface and periphery with no 
significant colocalization with LAMP-1.  The numbers of cells in each category were 
plotted as percentages of the total number of cells in the field (Fig. 3.2D).  After a 30 min 
chase at 37oC, the surface labeled BCR was extensively colocalized with the LAMP-1 in 
over 60% of cells expressing wt GFP-Dyn, compared to just 40% of cells expressing 
GFP-Dyn ∆PRD (Fig. 3.2C-D).  These results indicate that dynamin 2 is required for the 
movement of the BCR from the cell surface to the antigen processing compartments and 
that the PRD of dynamin 2 may be important for this function. 
 
3.4.3 Dynamin regulates F-actin and BCR interaction following BCR crosslinking.  
To examine the relationship between the actin cytoskeleton and dynamin during BCR 
internalization, we monitored actin dynamics in live cells. GFP-actin was transiently 
transfected into A20 B cells.  GFP-actin-expressing cells were stained with Cy3-Fab-anti-
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FIGURE 3.2. The PRD of Dynamin is important for BCR internalization. 
 (A) The experiments are presented as freeze frames of selected time points from movies 
taken of  B cell lymphoma A20 cells transiently transfected with Dynamin 2aa ∆ PRD 
GFP.  Twenty-four hours after transfection, surface BCR was labeled with Cy3-
conjugated goat anti-mouse IgG on 4-well chambered cover glasses and activated by 
crosslinking the BCR with rabbit anti-mouse IgG. Images were obtained every 3 seconds 
with a Zeiss confocal microscope. (B) A20 cells were transiently transfected with GFP-
Dyn or GFP-Dyn ∆PRD. Twenty-four hours later the surface BCR was labeled with 
biotin-F(ab’)2-goat anti-mouse IgG at 4oC and chased at 37oC for indicated times.  Biotin-
anti-mouse IgG left on the surface was detected by PE-streptavidin and quantified using a 
FACS Calibur.  The data was plotted as the percentage of the labeled BCR remaining at 
the cell surface.  Shown are the averages (±S.D.) of three independent experiments. ** p< 
0.01. (C) A20 cells were transiently transfected with GFP-Dyn or GFP-Dyn ∆PRD.  
Twenty-four hours after transfection, cells were labeled with AF546-conjugated goat 
anti-mouse IgG for 20 min at 4oC and chased for 30 min at 37oC.  Immediately following 
the chase, cells were fixed, permeabilized, and labeled with anti-LAMP-1 mAb for late 
endosomes.  Arrows indicate cells expressing transfected proteins (Bar, 10 μm).  (D) 
Quantification of the effect of over expression of GFP-Dyn or GFP-Dyn ∆PRD on the 
cellular distribution of the BCR.  Cells were divided into two different categories: cells 
showing extensive colocalization between the BCR and LAMP-1 and those showing no 
colocalization.  Cells were categorized by visual inspection.  Shown are the averages 
(±S.D.) of over 100 cells randomly selected from three independent experiments and 
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mouse IgG to label the BCR and treated with anti-mouse-IgG whole antibody to crosslink 
the BCR. The cellular distribution of GFP-actin and BCR was monitored in real time 
using a confocal fluorescence microscope (Fig. 3.3A-H). Prior to BCR crosslinking, 
GFP-actin was evenly distributed around the cytoplasm and showed some colocalization 
with the BCR (Fig. 3.3Aa). Upon BCR crosslinking, GFP-actin co-clustered with the 
BCR at a particular pole of the B cell (Fig. 3.3Ab).  The GFP-actin and BCR co-cluster 
increased in size over time and was sustained for about 20 min. This was followed by the 
BCR moving into the cell (Fig. 3.3Ac-h). Furthermore, GFP-actin remained colocalized 
with the BCR or located in the vicinity of the BCR when the BCR moved to the 
perinuclear location (Fig. 3.3Af-h). This revealed that BCR crosslinking mobilizes the 
actin cytoskeleton from the cytoplasm to the surface BCR, and the reorganized actin 
accompanies the BCR during its internalization and movement to the antigen processing 
compartments. We next examined the cellular distribution of dynamin 2 relative to GFP-
actin and the BCR. A20 B cells expressing either wt GFP-Dyn or its ∆PRD mutant were 
incubated with AF633-anti-mouse IgG for 10 min to label and cross-link the BCR.  After 
fixation and permeabilization, cells were stained with AF555-phalloidin for F-actin. It 
was observed that the both F-actin (red) and wt GFP-dynamin (blue) co-clustered with 
BCR (green) at the cell membrane (Fig. 3.3Ba-d). However, the co-clustering of F-actin 
and dynamin with the BCR was reduced in cells expressing GFP-Dyn ∆PRD (Fig. 3.3Be-
h). This result suggests that dynamin has the potential to play a role in directing the 
reorganization of the actin cytoskeleton to the BCR during BCR internalization. This 
hypothesis, however, remains to be tested fully. 
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FIGURE 3.3. Dynamin regulates F-actin and BCR interaction following BCR 
crosslinking.  
(A) B-cell lymphoma A20 cells were transiently transfected with GFP-Actin.  Twenty-
four hours after transfection, surface BCR was labeled with cy3 conjugated goat anti-
mouse IgG on 4 well chambered cover glasses and activated by crosslinking the BCR 
with rabbit anti-mouse IgG. Images were obtained every 3 seconds with a Zeiss confocal 
microscope, (bar, 10µm). Image shows freeze frames of selected time points and is 
representative of three independent experiments.  
(B). A20 cells transiently transfected with GFP-Dyn (a - d) or GFP-Dyn ∆ PRD (e - h) 
were activated with goat anti-mouse IgG for 10 min, and then fixed, permeabilized, and 
labeled with AF 555 Phalloidin to stain F-actin  Cells were analyzed using confocal 
fluorescence microscopy.  Shown are representative images of three independent 
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3.5 Discussion   
Here I show that dynamin 2 is recruited to the cell surface in a BCR signaling-dependent 
manner and that this recruitment depends on the PRD of dynamin 2. I also show that 
deletion of the PRD of dynamin 2 has a dominant negative effect on the internalization of 
the BCR as well as disrupting the colocalization of F-actin with the BCR on the plasma 
membrane.   
 
The role of dynamin in CME has been clearly elucidated (55, 91, 166). Dynamin acts as a 
GTPase that is recruited to the neck of nascent clathrin-coated vesicles and helps to 
generate the force that pinches of the clathrin-coated vesicles (91, 92). Studies have 
shown that mutations in the GTPase domain (167) as well as the PH domain (94) of 
dynamin can disrupt CME. The PRD of dynamin is required for the recruitment of 
dynamin to the cell surface by interacting with amphiphysin and mutations of this domain 
don’t seem to have any effect on endocytosis (91, 94). On the contrary, mutations in the 
PRD of dynamin inhibited the dominant negative effect of a PH domain deletion 
dynamin mutant on endocytosis in Cos-7 cells (94). My data shows that in B cells, 
deletion of the PRD had a dominant negative effect on BCR internalization as well as 
trafficking to the late endosomes (Fig 3.2). This was relatively surprising considering 
previous data to the contrary in other systems like the findings from the previously stated 
Cos-7 cells. It is possible that overexpressing the ∆PRD mutant might disrupt BCR 
internalization by inhibiting the interaction between the actin cytoskeleton and the 
endocytic machinery of the B-cell.  The PRD of dynamin is required for interacting with 
the actin cytoskeleton by binding a number of proteins that interact with the actin 
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cytoskeleton (59, 63, 77). Overexpressing the SH3 domain of some of these proteins had 
a dominant negative effect on CME.  These proteins include amphiphysin (53), syndapin 
(76), intersectin (96) and Abp1 (70). Work in our lab by Bruce Brown has also shown an 
involvement of the actin cytoskeleton in BCR trafficking (35). In the presence of 
cytochalasin D, an agent that disrupts the actin cytoskeleton, there was a preponderance 
of deeply invaginated long necked clathrin-coated pits reminiscent of the expression of 
dynamin mutants that block endocytosis (168). Interestingly Bruce showed that 
constitutive internalization of the BCR as well as the internalization of transferrin (both 
via CME) did not seem to be affected by the disruption of the actin cytoskeleton, 
implying that an intact actin cytoskeleton is not required for this form of CME. This 
implies that the actin cytoskeleton is required for driving the rapid internalization of the 
BCR once it is crosslinked but is not required for the constitutive internalization of the 
BCR. This might help explain the obvious discrepancy between our data and that of 
others, that showed a lack of involvement of the PRD of dynamin in other cell systems 
(91, 94). In addition, I observed that actin co-localized with the BCR and stayed with the 
BCR during BCR internalization (Fig 3.3a and b). I also noticed that F-actin, BCR and 
GFP-Dynamin 2 colocalized at the cell surface during BCR internalization. When I 
expressed GFP-Dyn ∆PRD there was a marked reduction in the extent of colocalization 
between these proteins (Fig 3.3b), implicating the PRD of dynamin in the regulation of 
the interaction between actin and the internalizing BCR.  These observations provide 
further evidence that the observed defect in BCR internalization in the presence of the 
GFP-Dyn ∆PRD might be due to a disruption in the recruitment of the actin cytoskeleton 
to the nascent BCR containing vesicles. 
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 Another possibility is that the ∆PRD mutant might have an effect on the GTPase 
function of dynamin in generating scission at the plasma membrane. This event is 
dependent on its ability to oligomerize at the plasma membrane during CME (91, 92). 
The oligomerization of dynamin has some dependency on its PRD (169), although this is 
a primary function of the GED. It is, therefore, possible that overexpression of a PRD 
deletion mutant may competitively inhibit dynamin from forming spirals at the sites of 
endocytosis and thus inhibit its GTPase activity. GFP-Dynamin 2 ∆PRD may also be 
interfering with the interaction of dynamin oligomers at nascent CCVs with other SH3 
domain containing proteins that link dynamin to the endocytic machinery  during  BCR 
internalization (55, 166). Examples include amphiphysin(170) and endophilin (51, 171).  
 
It is important to point out that, unlike GFP-Dyn 2, we did not observe the recruitment of 
GFP-Dyn ∆PRD to the cell surface (Fig 3.1) during the internalization of the BCR, which 
implies that the inhibition of dynamin 2 may be occurring at sites other than the plasma 
membrane. One example is the Golgi where interactions between dynamin 2 and 
cortactin link the actin cytoskeleton to Golgi transport and is required for the transport of 
newly formed proteins from the trans-Golgi network (172).  
 
The recruitment of dynamin 2 to nascent CCVs has been shown to be dependent on the 
interaction of its PRD with the SH3 domain of amphiphysin (53) as well as the 
interaction of the PH domain with membrane phospholipids, notably PI(4,5)P (94, 95). 
Studies on sonicated plasma membranes of Cos-7 cells show that dynamin accumulates 
with CCPs, while a mutant with a disrupted PRD did not (101). The recruitment of 
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dynamin 2 in response to PDGF stimulation was shown by Mark McNiven to be 
dependent on the PRD of dynamin 2 via an interaction with cortactin, an activator of the 
actin cytoskeleton (173). Therefore the inhibition of dynamin recruitment in the absence 
of the PRD domain could be as a result of its inability to interact with amphiphysin or 
some other protein at the cell surface. This scenario is, however, yet to be tested and 
should be investigated in the future. It will also be interesting to test what role 
amphiphysin plays in BCR trafficking.  
 
The recruitment of dynamin could also be dependent on BCR signaling. Work in our lab 
in collaboration with the Brodsky lab had shown that clathrin is recruited to the cell 
surface upon BCR crosslinking and that this recruitment is dependent on BCR signaling-
mediated phosphorylation of clathrin (33). In addition, previous work in our lab had 
shown that the Src kinase inhibitor PP2 inhibited the BCR crosslinking mediated 
recruitment of dynamin to the cell surface, implying that dynamin recruitment may also 
be signaling-dependent (Brown, B.K. unpublished observations). Dynamin 2 is tyrosine 
phosphorylated at Y231 and Y597 in rat endothelial cell lines in response to albumin 
binding to its receptor gp60, where it colocalized with caveolin, and the phosphorylation 
was Src kinase-mediated (174). The recruitment of dynamin 2 to the plasma membrane 
has also been observed at the immunological synapse formed between a T cell and an 
antigen-presenting cell (100). In this study, the researchers did not find any evidence of 
dynamin phosphorylation before or after T cell stimulation and suggested that the 
recruitment of dynamin 2 to the immunological synapse is not dependent on dynamin 
phosphorylation(100). Whether dynamin 2 is phosphorylated in response to BCR 
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crosslinking and accounts for its recruitment to the plasma membrane is not known and 
would be a study to be considered in the future. 
 
BCR signaling could also direct dynamin recruitment via activation of Btk. BCR 
crosslinking leads to the activation of Btk.  Btk is involved in the synthesis of PIP2, the 
precursor of PIP3, by recruiting phosphatidylinositol-4-phosphate 5-kinase (PIP5K) 
which  synthesizes PIP2 (16). The binding of the PH domain of dynamin to PIP2 is one 
of the mechanisms that recruits dynamin to the cell surface (94, 175). It will be 
interesting to test this hypothesis first by observing the role of the PH domain of dynamin 
during BCR crosslinking and also testing whether Btk plays a role in dynamin 
recruitment. 
 
One intriguing observation we made was the colocalization of dynamin with the BCR for 
a sustained period of time during endocytosis. Dynamin 2 not only colocalized with the 
surface BCR, but also colocalized with BCR-positive vesicles moving inward (Fig.3.1).  
Recent reports by Merrifield et al. pointed to a transient involvement of dynamin in CME 
(55, 156). The significance of our observation is not yet known. One possibility is that 
dynamin remains associated with the newly formed vesicle in order to direct F-actin 
reorganization at or near the neck of the nascent CCV and thus position the vesicle for 
trafficking towards the cell interior as against a more random movement if actin was 
polymerizing all over the vesicle.  A similar hypothesis for actin directing the inward 




The results presented here demonstrate that dynamin plays an essential role in the 
internalization of the BCR and may be regulated by BCR crosslinking-mediated signaling 
events. Future work will focus on the effect of other domains of dynamin on BCR 




 Chapter 4: Abp1, an actin adapter protein, is important for 




BCR crosslinking leads to the activation of signaling cascades that turn on transcription 
factors and the expression of genes required for B cell activation. Abp1 is an actin-binding 
adaptor protein that has been shown to be important in both clathrin-mediated endocytosis 
and signal transduction. In T cells, it regulates the activity of the MAP kinase, JNK, by 
interacting with HPK1, a MAP4K. Abp1 knockout mice have defective T-dependent 
antibody responses. In Chapter 2, we demonstrated a role for Abp1 in BCR-mediated antigen 
processing and presentation.  Here, we have studied the role of Abp1 in BCR signaling using 
Abp1 knockout and knock down approaches. In response to BCR crosslinking by antigen, 
splenic B cells from Abp1 knock out mice and A20 B cells transfected with Abp1 shRNA 
had higher levels of protein tyrosine phosphorylation than the wild type splenic B cells and 
untransfected A20 B cells.  While BCR-triggered ERK phosphorylation in Abp1-deficient B 
cells occurred sooner and for a much shorter duration than the wild type B cells, both Abp1 
knockout and knockdown significantly reduced BCR-induced phosphorylation of JNK.  





Crosslinking of the BCR by antigen leads to  activation of signal transduction pathways that 
lead to the transcription and translation of proteins required for B cell proliferation (176). 
The initial event of activation is the phosphorylation of tyrosine residues in the ITAM of Igα 
and Igβ by Src-family kinases (6).  The phosphorylated ITAMs recruit and activate tyrosine 
kinases, Syk, and adaptor proteins (14). The kinases and adaptor proteins activate 
downstream effectors that include phospholipase Cγ2, phosphatidylinositol-3-kinase, and 
Ras, which leads to calcium mobilization and activation of the MAP kinases, including ERK, 
JNK and p38.  The MAP kinases activate a host of transcription factors (14).  
 
Recent studies have provided evidence for links between the actin cytoskeleton and signal 
transduction pathway.  In B cells, BCR-mediated signaling regulates the actin cytoskeleton.  
BCR crosslinking by antigen induces polymerization and subsequent depolymerization of F-
actin (35). The binding of antigen to the BCR triggers the phosphorylation and activation of 
Vav, a guanidine nucleotide exchange factor for a Rho-family GTPase, Cdc42, which 
regulates the actin cytoskeleton (177). The actin cytoskeleton has been shown to influence 
the signal transduction events in B cells. Our lab previously showed that perturbing the actin 
cytoskeleton with cytochalasin D did not inhibit BCR-induced protein tyrosine 
phosphorylation, but extended the duration of the phosphorylation.  Hao et al. recently 
showed that F-actin depolymerization by latrunculin alone led to ERK activation in CH27 B 
cell lines (87). This indicates a regulatory relationship between the actin cytoskeleton and 
signal transduction pathway and implies a possible role for actin adaptor proteins in linking 
the actin cytoskeleton to the BCR signal transduction pathway.   
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Abp1 is a 55 kDa adaptor protein composed of various protein-protein interaction domains 
including two N-terminal actin binding domains, a PRD or flexible domain, and a C-terminal 
SH3 domain (115). Its PRD contains two tyrosine phosphorylation sites, Y337 and Y347 
(114). Mammalian Abp1 is a homologue of the Abp1 protein first found in yeast, and yeast 
Abp1 has an important role in yeast endocytosis (178). Similarly, Abp1 has been shown to be 
important for transferrin endocytosis in mammalian cells (70). Yeast Abp1 can directly 
regulate the actin cytoskeleton by interacting with N-WASP.  However, a similar function for 
mammalian Abp1 has not been observed.  In Chapter 2 of this thesis, we have shown a role 
for Abp1 in BCR-mediated antigen internalization and antigen presentation. Larbolette et al 
showed that Abp1 was phosphorylated at Y337 and Y347 by Src kinases Lyn and Blk and 
Syk in vitro (114). In Chapter 2, we showed that this phosphorylation was important for the 
recruitment of Abp1 to the surface of the B cells, suggesting that BCR signaling can regulate 
the cellular location of Abp1.  
 
Groups led by Tse-Hua Tan and Marcel Deckert have shown a role for Abp1 in T cell 
receptor-mediated signal transduction (119, 122, 123). Abp1 binds to hematopoetic 
progenitor kinase 1 (HPK1), a serine/threonine protein kinase (118) that negatively regulates 
T-cell signaling (121). HPK1 is a MAP4K that activates the JNK pathway in T cells (120, 
179, 180). Both HPK1 and JNK phosphorylation was attenuated in two T cell lines treated 
with Abp1 siRNA (119) and primary T cells from Abp1 knockout mice (123). Using RNA 
interference, Le Bras et al. found Abp1 to be a negative regulator of NFAT in Jurkat T cells 
(122), and Han et al. revealed defects in TCR- induced proliferation of T cells, IL-2 
production, and reduced levels of T-cell activation markers, notably CD69, in Abp1-/-.  In 
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response to TCR signaling, these defects in Abp1-/- were upstream of protein kinase C and 
calcium influx, because the response of the T cells to phorbol 12-myristate 13 acetate and 
ionomycin (which bypasses TCR signaling-induced activation of protein kinase C) was 
similar to that of wildtype cells (123).  Furthermore, Abp1-/- had reduced IgG1 production 
during both the primary and secondary immune response in Abp1-/- mice when immunized 
with specific antigens. There was also reduced T-cell proliferation and IL-2 production in 
response to the same antigen  (123), implying that Abp1-/- may play a role in antigen-specific 
immune responses in T cells.  Abp1-/- had reduced JNK and HPK1 activation, as well as a 
reduction in the phosphorylation of PLCγ1 and LAT in response to TCR stimulation. The 
role of Abp1 in BCR-mediated signaling pathways has not been examined.  As an actin 
adaptor protein, Abp1 has the potential to simultaneously interact with both F-actin and a 
signaling protein.   Its multiple domains for protein-protein interaction and F-actin binding, 
and its role in TCR-mediated signal transduction, suggest a role for Abp1 in the interaction of 
the actin cytoskeleton and signal transduction pathway in B cells.  
 
Using a mouse knockout model, we have started to examine the role of Abp1 in BCR-
mediated signaling. We found that both splenic B cells from Abp1 knockout mice (Abp1 -/-), 
and B cells treated with Abp1-specific siRNA, had higher levels of protein tyrosine 
phosphorylation than wt splenic B cells in response to BCR crosslinking. Both Abp1 
knockout and knockdown reduced BCR-triggered phosphorylation of JNK.  In addition, the 
activation kinetics of ERK was altered in Abp1-deficient splenic B cells. These demonstrate 




4.3 Materials and method 
4.3.1 Mice, cells and cell culture.   
B cell lymphoma A20 IIA1.6 cells (H-2d, IgG2a+, FcγRIIB-) were cultured at 37oC in DMEM 
supplemented with 10% FBS.  C57BL6 mice that were 6-8 weeks old were purchased from 
Taconic (Hudson, NY).  Abp1 knockout mice (Abp1-/-) in a C57BL6 background were 
established and kindly provided by Dr. Tse-Hua Tan at Baylor Medical College (Houston, 
TX).  To isolate splenic B cells, single-cell suspensions of splenocytes were subjected to 
density-gradient centrifugation (2300 x g) in Ficoll (Sigma-Aldrich, St Louis, MO) to obtain 
mononuclear cells, treated with anti-Thy1.2 mAb (BD biosciences, San Jose, CA) and guinea 
pig complement (Rockland Immunobiochemicals, Gilbertsville PA) to remove T cells, and 
panned for 2 h to remove monocytes. 
 
4.3.2 Developing of Abp1 shRNA.  
Sequences with the potential to target mouse ABP1 mRNA were designed using software 
provided by the Qiagen siRNA website. Four sequences were designed and ligated into a 
lentiviral vector pLL3.7 GFP (181) (this process was done with the assistance of Dr. Wenxia 
Song) and introduced into 293T cells with the packaging vectors (Invitrogen) using 
Lipofectamine to generate virus-infected 293T cells. Virus-containing supernatants were 
collected 36 h after infection. A20 cells were infected with the virus for 5 days. GFP-
expressing A20 cells were sorted for GFP expression by BD Aria and cloned by limiting 
dilution. Clones with Abp1 knockdown were screened by immunofluorescence microscopy. 
Cells were washed and adhered to poly-lysine-coated slides (Sigma-Aldrich) for 40 min at 
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4oC and then fixed with 4% paraformaldehyde. Cells were permeabilized with a 
permeabilization buffer (0.05% saponin, 10mM HEPES, 10mM Glycine and 10% Fetal 
bovine serum in DMEM) and stained for Abp1 using rabbit anti-Abp1 (70) and AF 633 
conjugated anti-rabbit mAb.  Cells were mounted with gel mount (Biomeda, Foster City, CA) 
and analyzed using a laser-scanning confocal microscope (LSM 510; Zeiss, Oberkochen, 
Germany).  Abp1 knockdown was confirmed by western blot. The shRNA sequence 
corresponding to AAGGATAACTTCTGGGCCAAA was shown to be effective in knocking 
down Abp1 expression and the sequence corresponding to AGCACCTCCTTCCAGGATGT 
showed no knockdown of Abp1, which will be used as control.  
 
4.3.3 Analysis of phosphorylation.   
Splenic B cells from wildtype C57BL6 and Abp1 knockout mice, as well as A20 B cells that 
express Abp1 shRNA, were activated by crosslinking the BCR with goat anti-mouse IgG+M 
(20 µg/ml, Jackson ImmunoResearch), or goat anti-mouse IgG (20 µg/ml, Jackson 
ImmunoResearch) for A20 B cells, for the indicated times and lysed in a lysis buffer 
containing 0.5% Triton X100, 20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM MgCl2, 1 mM 
EGTA, 1 mM Na3VO4, and protease inhibitors (Roche, Basel Switzerland). To test the effect 
of actin depolymerization on BCR signaling, splenic B cells were incubated with 2 µM 
latrunculin for 30 min before activating the cells.  Cell lysates were analyzed using SDS-
PAGE and Western blotting, probing with anti-phospho-tyrosine mAb (4G10, Upstate 
Biotech, Lake Placid, NY), rabbit anti-phosphorylated JNK (pJNK), rabbit anti-
phosphorylated ERK (pERK) (Cell signaling), and mouse anti-tubulin (IgG1 specific, Sigma) 
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4.4.1 Abp1 deficiency alters BCR-induced protein tyrosine phosphorylation. 
In order to study the role of Abp1 in BCR signaling, we attempted to knockdown Abp1 by 
the approach of siRNA. Abp1 knockdown had previously been reported in Jurkat T cells 
(119) and human embryonic kidney 293T (148). Due to low transfection efficiency of B-cell 
lines, we interfered with Abp1 expression by introducing shRNA using a lentiviral system.  
A short hairpin sequence that targeted the mRNA of Abp1 was inserted into a previously 
described vector (181) that was engineered to include a GFP cDNA for detection of shRNA-
positive cells. A20 B cells expressing four potential shRNA sequences were sorted for GFP 
expression. One of the sequences revealed a substantial inhibition of Abp1 expression by 
western blot analyses (Fig. 4.1A). Immunofluorescence microscopy analyses showed a 
decreased Abp1 staining in GFP-expressing cells (Fig. 4.1B). The cells were subsequently 
cloned and cells expressing the shRNA were selected. The expression level of Abp1 in A20 
cells that stably express Abp1 shRNA was less than 20% of wt cells (Fig. 4.1D). This shows 
that Abp1 can be significantly knocked down in A20 B cells by stably expressing Abp1 
shRNA. 
 
Using the A20 cell line in which Abp1 is stably knocked down, we examined the role of 
Abp1 in BCR signaling. A20 B cells with or without Abp1 knockdown, were incubated with 
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anti-mouse IgG to cross-link the BCR.  The cells were lysed, and the cell lysates were 
subjected to SDS-PAGE and Western blot, probing with antibodies specific for 
phosphotyrosine. A20 B cells expressing Abp1 shRNA had a significant increase in the level 
of protein tyrosine phosphorylation when compared with wt A20 B cells (Fig. 4.1C).  To 
further confirm the role of Abp1 knockdown in BCR signaling, a mouse knockout model of 
Abp1 knockdown was employed (123). The splenic B cells from both wt and Abp1-/- mice, 
on C57BL6 background, were incubated with anti mouse IgG + M for indicated times to 
activate the BCR.  Cells were lysed, and the lysates were analyzed by SDS-PAGE and 
western blot. As shown in Fig. 4.1E, crosslinking of the BCR induced protein tyrosine 
phosphorylation in both wt and Abp1-/- splenic B cells with the level of protein tyrosine 
phosphorylation in Abp1-/- splenic B cells significantly higher than wt ones.  Specifically, we 
observed increases in tyrosine phosphorylation for bands around 75KDa (Fig. 1F), 100KDa 
(Fig. 4.1G) and 120KDa (Fig. 4.1H), although the specific identity of these proteins is 
unknown. This result shows that Abp1 plays a role in BCR signaling by regulating BCR-











FIGURE 4.1. Abp1-deficiency alters BCR-induced protein tyrosine 
phosphorylation. 
 (A) Putative Abp1 shRNA’s were introduced into A20 B cells using the lentiviral 
system. shRNA-positive cells were sorted based on co-expressed GFP. Cells were lysed 
and the lysates were analyzed by SDS-PAGE and Western blot, probing for Abp1. (B) 
Mixture of A20 B cells expressing and not expressing Abp1 shRNA (Green) were fixed, 
permeabilized, and labeled with rabbit anti-Abp1 and an Alexa Fluor 546-conjugated 
secondary antibody. Shown are representative images of three independent experiments.  
(Bar, 10 μm).  The protein tyrosine phosphorylation of Abp1 shRNA-expressing A20 B 
cells in response to BCR activation was compared with wt A20 B cells using western 
blot.  Wt and Abp1 shRNA-expressing cells were incubated with goat-anti-mouse IgG for 
5 min to activate the BCR.  Then, cells were lysed, and the lysates were analyzed by 
SDS-PAGE and Western blot, probing with anti-phosphotyrosine mAb (4G10) (C).  The 
blots were stripped and reblotted with either anti-Abp1 or actin antibody (C).  (D) Shows 
Abp1 expression in both wt and Abp1 shRNA expressing cells, quantified using 
densitometry, and normalized to actin levels. (E) The protein tyrosine phosphorylation in 
response to BCR activation in splenic B cells from Abp1-/- mice was compared with that 
in wt splenic B cells using western blotting.  Splenic B cells were incubated with goat-
anti-mouse IgG + M for varying lengths of time to crosslink the BCR.  Next the cells 
were lysed, and the lysates were analyzed by SDS-PAGE and Western blotting, probing 
with anti-phosphotyrosine mAb (4G10). Shown is a representative of three independent 
experiments. (F-G) Phosphorylation levels for selected bands were quantified using 
 108
 
densitometry and normalized to tubulin levels. Shown is a representative of three 
independent experiments.  
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4.4.2 Abp1 deficiency alters BCR-induced phosphorylation of JNK and ERK. 
Abp1 has previously been shown to play an indirect role in JNK activation by interacting 
with HPK1, an upstream kinase of JNK  in T cells (119, 123).  To determine whether 
Abp1 plays a role in BCR-triggered JNK activation in B cells, we compared BCR-
triggered phosphorylation of JNK in wt and Abp1-/- splenic B cells. Western blot analyses 
using anti-phospho JNK antibodies showed that BCR crosslinking increased JNK 
phosphorylation in wt A20 B cells and splenic B cells (Fig. 4.2A ,B and C,D 
respectively), however, this increase in JNK phosphorylation was significantly reduced in 
Abp1-knockdown A20 B cells and Abp1-/- B cells (Fig. 4.2A ,B and C,D respectively). 
ERK phosphorylation resulting from BCR-mediated activation has been shown to be 
important for the proliferation of the B cell and the upregulation of B-cell activation 
markers (14).  To study the role of Abp1 in B-cell signaling, we compared the 
phosphorylation of ERK following BCR crosslinking in Abp1-/- and wt splenic B cells. 
ERK phosphorylation increased to a similar level in Abp1-/- and wt splenic B cells 2 min 
after BCR crosslinking. However, at 10 min, ERK phosphorylation in Abp1-/- B cells 
declined, while ERK phosphorylation in wt B cells remained high (Fig. 4.2C and E). We 
did not observe any obvious differences in BCR-induced phosphorylation of p38 between 




FIGURE 4.2. Abp1-deficiency alters BCR-induced phosphorylation of JNK and 
ERK. 
The phosphorylation of JNK in Abp- shRNA expressing A20 B cells in response to BCR 
activation was compared with wt A20 B cells using western blotting.  Wt and Abp1 shRNA 
expressing cells were incubated with goat-anti-mouse IgG for 5 min to crosslink the BCR.  
Next the cells were lysed and the lysates were analyzed by SDS-PAGE and Western blot. 
Blots from Fig 4.1C were stripped and probed with anti-phosphorylated JNK (pJNK) mAb 
(A).  The blots were stripped and re-probed with either anti-Abp1 or actin antibody.  (B) 
Shows pJNK level in both wt and Abp1-shRNA expressing cells quantified using 
densitometry and normalized to actin levels. (C) The phosphorylation of JNK, ERK and p38 
in response to BCR activation in splenic B cells from Abp1-/- mice was compared with that in 
wt splenic B cells using western blotting.  Blots from Fig 4.1E were stripped and probed with 
anti-pJNK, anti pERK and anti p38 mAb.  JNK (D) and ERK (E) phosphorylation levels in 
Abp1-/- and wt mice were quantified using densitometry and normalized to tubulin levels. 




-XL  +XL  -XL  +XL  (+XL = 5 min)





































C WT Abp1 -/-










































































4.4.3 Alteration of BCR signaling in Abp1-/- B cells is not simply caused by 
reduced BCR internalization. 
In the previous chapter, we demonstrated that the internalization rate of the BCR was 
reduced in Abp1-/- B cells. In order to test whether the increase in BCR-induced protein 
tyrosine phosphorylation is a result of reduced BCR internalization, we compared the 
protein tyrosine phosphorylation levels in Abp1-/- 
 
splenic B cells with wt splenic B cells treated with latrunculin, which blocks BCR 
internalization through actin depolymerization (35). We did not observe a similar increase in 
protein tyrosine phosphorylation in latrunculin-treated B cells as seen in Abp1-/- B cells (Fig. 
4.3B). This result suggests that inhibition of BCR internalization is not the sole cause of 
upregulated protein tyrosine phosphorylation in Abp1-/- B cells. Furthermore, in latrunculin-
treated splenic B cells, we observed that BCR-induced ERK phosphorylation was 
considerably higher than in cells that were not treated with latrunculin (Fig. 4.3A and B). 
This is in sharp contrast to Abp1-/- mice where there was a substantial attenuation of ERK 
phosphorylation (Fig. 4.2C and E). This result is in line with a previously published report 
showing that latrunculin-treatment enhances BCR-induced ERK phosphorylation (87).  In 
addition, JNK phosphorylation was higher in latrunculin treated splenic B cells when 
compared with wt (Fig. 4.3A and B) contrasting with what was observed in Abp1-/- (Fig. 
4.2C and E) where JNK activation was attenuated. This further supports the conclusion that 
the altered signaling profiles observed in Abp1-/- mice may not be connected to the observed 




FIGURE 4.3. Defect in BCR internalization is not sufficient to explain signaling 
defect in Abp1-/-. 
(A) The protein tyrosine phosphorylation in response to BCR crosslinking in latrunculin-
treated splenic B cells was compared with that in wt splenic B cells using western 
blotting. Splenic B cells were treated with or without 2μM latrunculin for 30 min and 
incubated with goat-anti-mouse IgG for varying lengths of time to crosslink the BCR.  
Then the cells were lysed, and the lysates analyzed by SDS-PAGE and Western blotting, 
probing with anti-phosphotyrosine, (4G10) anti-pJNK and anti-pERK mAb. Shown is a 
representative of two independent experiments. ERK (B) and JNK (C) phosphorylation 
levels in wt and latrunculin-treated wt splenocytes were quantified using densitometry 
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Abp1, an actin adaptor protein, plays an important role in T cell signaling.  In T cells, Abp1 
regulates the function of the MAP kinase, JNK, via interactions with HPK1 (123). However, 
the role of Abp1 in B cell signaling has not yet been studied.  In this study, we showed that 
both Abp1 knockdown and knockout enhanced BCR-induced protein tyrosine 
phosphorylation, and reduced BCR-induced phosphorylation of the MAP kinases JNK and 
ERK.  These results demonstrate an important role for Abp1 in BCR-mediated signaling. 
 
The attenuation of JNK activation observed in B cells was similar to previously published 
reports in Abp1-/- T cells (123).  The same report showed a defect in p38 activation in Abp1-/- 
T cells.  However the effect of Abp1-deficiency on TCR-induced ERK activation has not 
been reported. In B cells, ERK phosphorylation, but not p38 phosphorylation was altered by 
Abp1 deficiency, suggesting that Abp1 regulates BCR signaling by a mechanism different 
from TCR signaling. The regulatory role of Abp1 in TCR signaling has been attributed to the 
interaction of Abp1 with HPK1, a MAP4K.  This interaction regulates the activation of 
HPK1 (119, 120, 122, 123) which activates JNK through MAP3K, e.g. MEKK1 (180, 182). 
Whether or not Abp1 uses a similar mechanism to regulate the activation of JNK in B cells 
remains to be tested.    
 
Alteration of BCR-triggered tyrosine phosphorylation levels of multiple proteins was 
observed in Abp1 knockdown and knockout B cells, suggesting the involvement of Abp1 in 
the proximal signaling of the BCR. BCR crosslinking by antigen results in the translocation 




important for BCR signaling (9, 33, 183, 184). Previously published data show that Abp1 is 
translocated into glycolipid-enriched microdomains  (also described as lipid rafts) formed at 
the T-cell synapse following antibody stimulation of the TCR (119, 122). This recruitment is 
followed by the phosphorylation of Abp1 by ZAP70 (119).  Previously published reports also 
show that the recruitment and phosphorylation of Abp1 at the T cell synapse occurs 
concurrently with HPK1 recruitment following TCR activation (122).  Although Abp1 binds 
constitutively with HPK1 (119, 122), it is possible that the recruitment of Abp1 directs the 
recruitment of HPK1 in T cells as well. The observation that BCR-triggered protein tyrosine 
phosphorylation was upregulated in both Abp1-/- and Abp1 knockdown B cells suggests a 
negatively regulatory role for Abp1 in BCR signaling and this may be due to its interaction 
with HPK1.  A recent report showed that HPK1 serves as a negative regulator of T-cell 
function (121).  HPK1 deficiency resulted in the enhanced phosphorylation of SLP-76, PLC-
γ1 and enhanced calcium influx (121).  Abp1 has the potential to recruit HPK1 to the BCR-
signaling microdomain, permitting HPK1 to regulate BCR signaling, and this could help 
explain the observed defect in BCR signaling dependent tyrosine phosphorylation in Abp1 
deficient B cells.   
 
In the second chapter my observations show that Abp1 knockout and knockdown can inhibit 
BCR internalization. This may prolong the lifetime of BCR surface signaling microdomains 
and enhance proximal signaling. However, inhibiting BCR internalization by disrupting the 
actin cytoskeleton with latrunculin gave a markedly different signaling profile, suggesting 
that enhanced BCR signaling due to defects in internalization cannot fully explain the 




showed substantial increases in activation. This included bands that corresponded to 
approximately 75, 100 and 120 kDa. Speculating on the identity of these proteins based on 
molecular weight alone is difficult, since the accuracy of the markers used in SDS/PAGE is 
limited, and a long list of signaling proteins exist at this molecular weight range. Determining 
the identity of these proteins, by either mass spectrometry or some other method, should 
provide important clues about what stage in the BCR signaling cascade Abp1 might be 
exerting its influence.    
 
Surface-signaling microdomains formed by coalescing of BCR and signaling molecules in 
the lipid rafts, are similar to the immunological synapses between T cells and APCs. A role 
for the actin cytoskeleton has been described in the successful formation of the synapse in T 
cells and one of the major defects observed in WASP (a regulator of the actin cytoskeleton) 
knockout mice was an inability to form a synapse between the APC and the T-cell (111). 
Vav-deficient mice (a GEF for Rac) have defects in synapse formation in T cells (100, 177). 
It has also been shown in B cells that actin plays a role in regulating the lipid-raft complex 
formed after BCR crosslinking. It was observed that disrupting the actin cytoskeleton led to a 
delay in the BCR crosslinking-induced internalization of the lipid rafts and may explain the 
sustained ERK signaling observed in the presence of actin-disrupting agents (87). It is 
possible that Abp1’s activity might be connected to the actin cytoskeleton. It was observed 
that Abp1 recruitment to the cell surface was disrupted in the presence of latrunculin, an 
actin-disrupting agent, indicating that Abp1 function is dependent on an intact actin 
cytoskeleton (Unpublished observations). This allows us to envision a scenario where the 




plasma membrane, where it is phosphorylated by Src kinases and it acts as an adaptor protein 
that helps transduce signals generated by BCR crosslinking to downstream effectors. The 
identity of these downstream effectors is not known although obvious candidates include 
HPK1, which regulates JNK activity (180, 182).  This may explain the attenuation I observed 
in JNK activation. A proteomic approach can be used to identify other proteins that might be 
regulated by Abp1. 
 
Bam32, an actin adaptor protein, has recently been shown to be important for BCR-induced 
reorganization of the actin cytoskeleton via interactions with Rac1 (85, 86, 88). Splenic B 
cells, from Bam32-deficient mice and Bam32-deficient DT40 cells, shared similar JNK and 
ERK activation defects as Abp1-/- B cells. Bam32 was shown to interact with HPK1, and 
Bam32-/- mice had defective HPK1 activation in B cells (185), reminiscent of the phenotypes 
observed in T cells from  Abp1-/- mice (123). Furthermore, both Abp1 and Bam32 are 
recruited to the plasma membrane and tyrosine phosphorylated following BCR-mediated 
activation (114, 185). However, Bam32 is involved in regulating the actin cytoskeleton, 
while Abp1 function in mammalian cells seems to be dependent on the actin cytoskeleton. 
Although no functional relationship between Abp1 and Bam 32 has been established, 
similarities shared by Abp1 and Bam32 deficiency indicate the involvement of these two 
proteins in the same pathway.  It is possible that both of these proteins are part of a 
signalsome complex that is maintained by the actin cytoskeleton and is required for optimal 
BCR signaling. A recent report by Batista’s group showed the formation of signaling 
microclusters composed of antigen-crosslinked BCR, tyrosine phosphorylated proteins, and 




is also dependent on an intact actin cytoskeleton as a well as a number of actin binding 
proteins like Abp1 that might help with recruiting signaling proteins to these microclusters. 
 
The data presented here clearly show a role for Abp1 in regulation of BCR-mediated 
signaling.  However, the underlying mechanism for the regulatory role of Abp1 has not been 
well defined.  Future work will focus on the impact of Abp1 knockout on HPK1 activity and 
downstream transcription factor activation in B cells as well as the functional and physical 




 Chapter 5: General discussion 
 
The main objective of my thesis was to study how BCR signaling regulates the 
interaction of the actin cytoskeleton with the endocytic machinery of the B cell leading to 
the rapid internalization of antigens and their successful processing and presentation.  
 
The B cell is a major component of the adaptive immune response.  It is capable of 
recognizing an incredibly diverse array of antigens with its clonally specific receptor, the 
BCR. Multivalent antigens that can crosslink these receptors trigger a series of signaling 
events that lead to signaling-dependent internalization and processing of the antigen in 
MHC class II-containing compartments for the eventual presentation of the processed 
antigens to T cells on the surface of the B cell. The mechanism by which BCR signaling 
upregulates its own internalization is still being worked out. Previous work in Dr. Song’s  
laboratory showed that a dynamic actin cytoskeleton is required for the efficient 
internalization of the BCR following BCR crosslinking (35). Furthermore, we showed 
that BCR signaling regulates major proteins that are required for endocytosis of the BCR, 
notably clathrin (33). These studies and studies from other laboratories point to an 
intimate relationship between BCR signaling and the molecular events that direct the 
internalization of the BCR, and elucidating these mechanisms has been the primary focus 
of the lab. 
 
In this thesis, I demonstrate that Abp1 is a linker that connects the actin cytoskeleton to 




mediates this connection by interacting with both F-actin and dynamin, and these 
interactions are important for the efficiency of BCR-mediated antigen processing and 
presentation. The interaction between dynamin and Abp1 depends on the PRD of 
dynamin and the SH3 domain of Abp1, respectively, and this was confirmed by co-
immunoprecipitation and GST-based precipitation. This was further supported by the 
inhibitory effect seen with overexpression of the SH3 domain of Abp1 or the PRD 
deletion mutant of dynamin on BCR internalization and movement to the antigen 
processing compartment. These results underscore the importance of both Abp1 and 
dynamin in antigen-induced BCR internalization and BCR-mediated antigen processing 
and presentation.  Antigen-induced BCR internalization is  primarily clathrin-mediated 
(33, 140), and the role of dynamin in pinching off nascent vesicle during CME has been 
well documented (55, 91). A role for dynamin in linking the endocytic vesicle to the actin 
cytoskeleton during CME has also begun to emerge (59, 63, 77).  My data describes a 
critical link between the actin cytoskeleton and the internalizing BCR, mediated by the 
interaction between dynamin and Abp1.  
 
The rapid internalization of the BCR following antigen crosslinking is accompanied by 
the efficient processing of the antigen in the MIIC compartment and the eventual 
presentation of the antigen in the context of the MHC (14, 187).  The efficient delivery of 
antigen to the MIIC and its subsequent processing has been shown to be dependent on 
BCR-mediated signaling (42). The engagement of the BCR by antigen triggers the 
phosphorylation of ITAMs on Igα/Igβ, and the phosphorylation sites of the ITAM are 




compartment or MIIC compartment (34, 42, 43, 132, 154). Following BCR crosslinking, 
the phosphorylated ITAMs on Igα/Igβ recruit the tyrosine kinase Syk, which activate a 
number of signaling and adaptor molecules (14). Overexpression of a Syk mutant that 
does not interact with the phosphorylated ITAMs on Igα leads to defects in antigen 
presentation (132). These further indicate that BCR-induced signaling regulates the 
antigen processing and presenting functions of the BCR.  The reduction of the efficiency 
of BCR-mediated antigen processing and presentation in Abp1-knockout mice indicates 
the importance of Abp1 in this process. This defect can be explained by the reduced rates 
of BCR internalization and movement to the antigen-processing compartment in Abp1 
knockout mice.   
 
The interaction of Abp1 with dynamin provides a link between Abp1 and the endocytosis 
machinery.  However, the link between Abp1 and the machinery responsible for targeting 
of antigens to the MIIC is not known. In this thesis, I show that dynamin was recruited to 
the BCR at the plasma membrane upon BCR activation and maintained its colocalization 
with the BCR when it was on its way to the late endosomes. This sustained colocalization 
and trafficking of dynamin with the internalized BCR is disrupted by deleting the PRD of 
dynamin, suggesting that interactions mediated by this domain are important for co-
trafficking dynamin with the BCR to the antigen processing compartment.  I hypothesize 
that dynamin recruits the actin cytoskeleton to BCR-containing vesicles, which provides 
not only the driving force for the intracellular movement but fusion of these vesicles to 
their targets. Previous studies have shown that actin comet tails provide a mechanism for 




shown to be a part of the actin comet (189).  A working model can therefore be 
envisioned whereby BCR activation recruits dynamin to BCR containing clathrin-coated 
pits or vesicles, where it recruits F-actin by interacting with actin binding proteins, such 
as Abp1 or induces localized actin polymerization by binding to actin regulating proteins.  
The interaction of dynamin with Abp1 could provide actin nucleation sites in the vicinity 
of the BCR for active actin polymerization and branching.  The localized polymerization 
of actin could then generate the force that moves BCR-containing clathrin-coated pits and 
vesicles. 
 
How does BCR signaling regulate the interaction between the actin cytoskeleton and 
BCR endocytosis machinery?  Tyrosine phosphorylation of Abp1 is induced by PTKs 
Syk, Lyn and Blk in in vitro kinase assays (114). Here, I show that Abp1 is recruited to 
the BCR in a phosphorylation-dependent manner, since mutating the tyrosine 
phosphorylation sites to phenylalanine inhibited the recruitment. The particular kinase 
responsible for phosphorylating Abp1 in response to BCR activation in vivo is not known 
and should be a topic for future studies. Syk is a kinase that could be a likely candidate 
for regulating Abp1.  In addition to being the potential kinase for Abp1 phosphorylation, 
Syk could regulate the subcellular location of Abp1 by modulating the actin cytoskeleton 
organization. Syk-mediated regulation of the actin cytoskeleton has recently been 
reported to be important for the endocytosis and intracellular trafficking of BCR–antigen 
complexes (84). Using a Syk-deficient A20 cell line, Le Roux et al. showed that the 
targeting of BCR–antigen complexes to the MIIC compartments as well as the formation 




unlike wildtype A20 cells, where the actin cytoskeleton colocalized with the MIIC 
compartment, Syk deficient cells had a disorganized actin cytoskeleton. How Syk 
regulates the actin cytoskeleton has not been fully elucidated. Syk has been shown to 
activate Vavs, which are guanine exchange factors for Rho-family GTPases, Rac and 
Cdc42, both key regulators of the actin cytoskeleton (190, 191). Another possibility is 
that Syk might phosphorylate and thus recruit Abp1 to the BCR. This enables Abp1 to 
connect the BCR-antigen complex to the actin cytoskeleton and thus direct the complex 
to the late endosomes.  
 
BCR signaling may also regulate dynamin function and potentially direct its interaction 
with Abp1. Collaborative work with the Brodsky lab has shown that clathrin is recruited 
to the cell surface upon BCR crosslinking and this recruitment is dependent on BCR 
signaling mediated phosphorylation of clathrin (33). In addition, previous work in our lab 
has shown that the Src kinase inhibitor PP2 inhibits BCR crosslinking-mediated 
recruitment of dynamin to the cell surface, implying that dynamin recruitment may also 
be signaling-dependent (Brown, B.K. unpublished observations). Dynamin 2 is 
phosphorylated in a Src-dependent manner at Y231 and Y597 in rat endothelial cell lines 
in response to albumin binding to its receptor gp60, where dynamin 2 colocalized with 
caveolin (174). The recruitment of dynamin 2 to the plasma membrane has also been 
observed at the immunological synapse formed between a T cell and an antigen 
presenting cell (100). The researchers, however, did not find any change in dynamin 
phosphorylation before and after T cell stimulation and suggested that the recruitment of 




As discussed previously, my data shows that dynamin 2 is recruited to the cell surface 
following BCR crosslinking where it colocalizes with the BCR.  This could be a direct 
result of BCR signaling-dependent phosphorylation (or dephosphorylation) of dynamin. 
It is also possible that proteins responsible for recruiting dynamin are regulated by BCR 
signaling and, hence, indirectly recruit dynamin to the cell surface.  My data supports this 
hypothesis by showing that deleting the PRD of dynamin inhibits the recruitment of 
dynamin to the cell surface.  The PRD of dynamin is responsible for binding to a number 
of SH3 domain-containing proteins that are involved in the endocytic process, notably 
endophilin and amphiphysin (51, 54, 102, 171). These proteins could be directly 
regulated by BCR signaling, which then regulate dynamin indirectly.  Dynamin binding 
to amphiphysin via its PRD has been shown to be required for its recruitment (91). So, it 
is plausible that BCR signaling might regulate amphiphysin, which, in turn, recruits 
dynamin to the cell surface. This hypothesis is further buttressed by the fact that 
amphiphysin is itself recruited to the plasma membrane by binding to the α-adaptin 
subunit of AP-2 (102), which is recruited with clathrin in a BCR signaling-dependent 
manner ((33) and Bruce Brown unpublished observations).  Interestingly, amphiphysin 
phosphorylation prevented it from binding to AP-2, while dephosphorylation enhances its 
binding to AP-2 in synaptic vesicles (103). It will be interesting to study the regulation of 
these proteins during BCR signaling and whether they have any effect on dynamin 
regulation. 
 
In addition to a role for Abp1 in endocytosis, studies in T cells using both siRNA (119, 




recruitment to the T cell side of the APC – T cell immune synapse is dependent on both 
the SH3 domain and the ADH domain of Abp1 (122).   Abp1 knockdown using siRNA 
results in a reduced expression of the TCR, indicating a possible defect in the recycling of 
the TCR to the cell surface (122).  In T cells, Abp1 interacts with the kinase HPK1 (118), 
and this interaction is required for the activation of HPK1, a MAP4K that acts in the JNK 
pathway (180). Furthermore, Abp1-/- mice have defects in the activation of LAT, PLCγ1, 
HPK1 and JNK in T cells, and these may contribute to defects in T cell-derived IL-2 
production as well as proliferation. Thus, Abp1 may be involved in both proximal and 
downstream signaling from the TCR.  We delineate a role for Abp1 in BCR-mediated 
signaling as demonstrated by enhanced tyrosine phosphorylation and altered JNK and 
ERK signaling in splenic B cells from Abp1-/- mice. However, the exact role of Abp1 in 
BCR signaling, though significant, remains undetermined. The enhanced tyrosine 
phosphorylation suggests that Abp1is a regulator for BCR signaling. Such a regulatory 
effect could be mediated by the interaction of Abp1 with HPK1.   HPK1 has recently 
been shown to be a negative regulator of T cell signaling (121). T cells from HPK1 
knockout mouse display hyper-responsiveness to TCR stimulation as indicated by 
enhanced phosphorylation of PLCγ1, ERK and SLP-76, increased proliferation, cytokine 
production and humoral response (121). Abp1-deficiency may cause defects in the 
recruitment to and phosphorylation of HPK1 at the plasma membrane, consequently 
failing to activate JNK. The interaction of Abp1 and HPK1 in B cells however, has not 
yet been reported. Recent reports have described a link between Bam32, a BCR adaptor 
protein, and HPK1 in B cells, where Bam32 was shown to directly interact with HPK1 




similar role for Abp1 and Bam32 in regulating JNK activation in B cells, indicating that 
these two proteins may have a functional relationship, this, however, remains to be 
elucidated.  
 
My studies reveal an important function performed by Abp1 in linking, BCR signaling, 
antigen processing and presentation pathways, and the actin cytoskeleton.   Abp1 
facilitates BCR-mediated antigen internalization and subsequent processing and 
presentation in response to BCR activation by interacting with F-actin and dynamin.  
Additionally, Abp1-facilitated BCR internalization and the interaction of Abp1 with 
HPK1 potentially provide feedback signals for BCR-triggered signaling cascades.   
 
5.1 .Future studies 
While my research has revealed important roles for Abp1 and dynamin in BCR signal 
transduction, endocytosis and intracellular trafficking, a number of questions remain. 
 
The coordination of the endocytic machinery with the actin cytoskeleton during BCR 
signaling and internalization is not well understood. Live imaging studies of the 
interaction between dynamin and Abp1 would help shed some light on its nature. Studies 
using Fluorescence Resonance Energy Transfer (FRET) between tagged proteins can 
provide critical visual data on the interaction between these two proteins during BCR 
signaling and internalization. The kinetics of the interaction between the endocytic 




membrane using total internal reflection microscopy (TIRF) to determine the timing of 
BCR movement from the plasma membrane, the involvement of the actin cytoskeleton as 
well as other proteins that may be connected to BCR endocytic machinery.  
 
My research has revealed that dynamin and Abp1 seem to be regulated by BCR 
signaling. The precise nature of their regulation, however, is yet to be determined. It will 
be important to determine exactly how BCR signaling might be regulating both Abp1 and 
dynamin. Previous work in our lab by Bruce Brown has revealed disruption of dynamin 
recruitment in the presence of PP2, a Src kinase inhibitor. This raises the possibility that 
BCR signaling might directly regulate dynamin recruitment by phosphorylating dynamin. 
To test this, dynamin can be immunoprecipitated with antibodies, and the 
phosphorylation of dynamin can be detected with anti-phospho-tyrosine mAb using 
SDS/PAGE and western blotting.  Furthermore, a dynamin mutant lacking its two 
tyrosine phosphorylation sites (Y231/597F) has recently been developed by Dr. McNiven 
(personal communications with Dr. Song). The effect of these mutations on dynamin 
recruitment and colocalization with the BCR following BCR crosslinking can be 
monitored. The regulation of dynamin by BCR signaling could also be indirect, and 
proteins that recruit dynamin to the endocytosis machinery may exert a regulatory effect 
on dynamin by their recruitment to the plasma membrane during BCR signaling. 
Amphiphysin is a protein that could potentially regulate dynamin activity during BCR 
signaling. Future work would test if amphiphysin is regulated by BCR signaling and 
whether it is responsible for recruiting dynamin to the B cell surface in response to BCR 




after BCR activation and the effect of Src kinase inhibitors and/or phosphatase inhibitors 
on its cellular localization. It can also be tested whether the SH3 domain of amphiphysin, 
which potentially interacts with dynamin (53, 102), has a dominant negative effect on 
dynamin recruitment and BCR internalization.   
 
Although BCR internalization has been shown to be dependent on the clathrin-mediated 
endocytic pathway (33, 140), the importance of dynamin in BCR internalization and 
trafficking has not been determined.  The work in this thesis underscores the significance 
of dynamin in BCR internalization, since overexpressing a dynamin 2 mutant with a 
deletion of its PRD in A20 cells caused a significant reduction in BCR internalization and 
trafficking, implying that dynamin and its PRD are important for BCR internalization. A 
role for the PRD of dynamin in CME is, thus far, unreported, and a unique role for 
dynamin in BCR internalization is implied (91, 94). To determine how dynamin ∆PRD 
might disrupt BCR endocytosis, the effect of overexpressing a dynamin ∆PRD mutant on 
the recruitment of endogenous dynamin should be determined.  Tests should also be 
conducted to determine the extent of oligomerization of endogenous dynamin with the 
∆PRD mutant before and after BCR crosslinking by immunoprecipitation, which will 
provide answers to the question of whether disrupting dynamin oligomerization is the 
mechanism for defects caused by the ∆PRD mutant. The effect of other mutants of 
dynamin, which have been shown to inhibit CME, on the internalization and intracellular 
trafficking of the BCR, should also be tested: Notably, the mutant K44A that disrupts the 
GTPase function of dynamin (192) and mutations in the pleckstrin homology domain that 




The role of dynamin in signal transduction in lymphocytes is an emerging area of 
research. Studies reported by Gomez et al. (100), show that dynamin is important for 
regulating actin-dependent formation of synapses by recruiting Vav to the synapses. In 
addition, they suggested dynamin having  a role in forming a signaling scaffold in T cells 
(100). Dynamin has also been known to bind to Grb2 (97, 193) and PLC-γ1 (194) two 
major signaling molecules in lymphocytes.  Dynamin could, therefore, play a significant 
role in BCR signal transduction, and studies should be done to determine its role in 
modulating BCR signaling. The effect of dynamin on BCR signaling could be tested 
using shRNA-mediated knockdown of dynamin as well as over-expressing dynamin in 
cell lines, a system that has already been developed in our lab. Furthermore, co-
immunoprecipitating dynamin or co-precipitation using GST pull down with the PRD of 
dynamin can be used to look for interacting signaling partners, following antigen 
crosslinking of the BCR.  
 
The role of Abp1 in BCR signal transduction is yet to be elucidated. My research shows 
that Abp1-knockout mice have defects in the BCR-mediated activation of the ERK and 
JNK MAPK pathways. Further studies will shed light on how Abp1 might be regulating 
these pathways following BCR crosslinking. One likely mechanism is the interaction of 
Abp1 with HPK1 through their SH3 and PRDs respectively (119, 120, 180). Future 
studies should address the status of HPK1 activation following BCR crosslinking and the 
effects of knocking out Abp1 on the activation of HPK1. These experiments will address 
the functional link between Abp1 and HPK1 in B cells and the regulation of this link by 




upstream of JNK.  The observation that Abp1-knockout mice and Bam32-knockout mice 
have similar defects in JNK and ERK activation as well as BCR internalization (23, 86) 
may provide an important link as to how Abp1 might be regulating JNK and ERK 
activation. Both Abp1 and Bam32 are recruited to the plasma membrane where they are 
tyrosine phosphorylated following BCR crosslinking (unpublished observations and 
(88)).  Additionally, both of them interact directly with HPK1: Abp1 in T cells (119) and 
Bam32 in B cells (185).  A known difference between the two is that Bam32, but not 
Abp1 is involved in regulating actin polymerization (85) (unpublished observations). 
Based on the similarities between Bam32- and Abp1-knockout mice, it is possible that 
Abp1 and Bam32 regulate the formation and stabilization of BCR signaling 
microdomains by modulating actin dynamics and organization, consequently influencing 
the activation of upstream kinases of the JNK and ERK pathways. Future studies should 
focus on the interactions between Bam32 and Abp1. Another interesting question is 
whether Bam32 regulates Abp1 function. To test this, initial studies will focus on the 
cellular location and phosphorylation status of Abp1 in B cells from Bam32-knockout 
mice before and after BCR crosslinking. The interaction between Abp1 and Bam32 can 
also be followed by the colocalization and FRET between these two proteins.  
 
The JNK and ERK kinase pathways also play significant roles in antigen induced 
activation of the B-cell, leading to proliferation and upregulation of various activation 
markers (14).  BCR signaling induced ERK activation leads to activation of cyclin D 
which is important for cell cycle progression (195), while activation of JNK activates the 




clear, but it seems to be anti-apoptotic (197) and may aid in proliferative responses to 
BCR signaling (185). It will be important to determine what effect Abp1 knockdown 
might have on B cell proliferation following BCR crosslinking.  
 
Studies on yeast Abp1 point to a negative feedback role for Abp1 in yeast endocytosis 
(157), and there is a potential for this role to exist in mammals. S. cerevisiae has two 
actin-regulating kinases, Ark 1 (actin regulating kinase 1) and Prk1 (p53 regulating 
kinase), that are involved in shutting down actin polymerization at the sites of newly 
formed endocytic vesicles (198, 199). Abp1 recruits these proteins to endocytic sites in 
yeast (200). The mammalian homologues of these two kinases are AAK (adaptor protein 
complex 2 associated kinase 1) and GAK (cyclin G associated kinase) (157). 
Interestingly GAK is the ubiquitously expressed form of the neuronal-specific protein 
auxilin, a protein involved in the decoating steps of CME (201). The interaction between 
Abp1 and GAK in mammalian systems has not yet been reported. However, GAK 
recruitment was shown to coincide with that of dynamin recruitment during CME (201). 
It will be interesting to test whether Abp1 is able to regulate GAK’s function either 
directly or indirectly in mammalian systems and if this will have any impact on 
endocytosis. 
 
Elucidating the link between the signals generated by antigen crosslinking of the BCR 
and the effective processing and presentation of the antigen will enable better 
understanding of the complexities of the B cell mediated immune response. This will 




in part by defects in the humoral immune response. These conditions include 
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